University of Wisconsin–Madison

Publications, Presentations, Leadership, Service, and Awards

PUBLICATIONS

  1. Wang Z, Guzman EC, Nimunkar A, Keil KP, Vezina CM, Ricke WA, Macoska J, Bjorling DE (2019). Void Sorcerer: an Open Source, Open Access Framework for Mouse Uroflowmetry. IN PRESS. Am J Clin Exp Urol.
  2. Liu TT, Rodgers A, Nicholson TN, Macoska JA, Marker PC, Vezina CM, Bjorling DE, Roldán-Alzate A, Hernando D, Lloyd GL, Hacker T, Ricke WA (2019). Ultrasonography of the Adult Male Urinary Tract for Urinary Functional Testing. IN PRESS. JOVE.
  3. Sehgal PD, Bauman TM, Nicholson TM, Vellky JE, Ricke EA, Tang W, Xu W, Huang W, Ricke WA (2019). Tissue Specific Quantification and Localization of Androgen and Estrogen Receptors in Prostate Cancer. IN PRESS. Human Pathology.
  4. Liu TT, Thomas S, McLean DT, Roldán-Alzate A, Hernando D, Ricke EA, Ricke WA (2019). Prostate Enlargement and Altered Urinary Function Are Part of the Aging Process. IN PRESS.
  5. Turco AE, Cadena MT, Zhang HL, Sandhu JK, Oakes SR, Chathurvedula T, Peterson RE, Keast JR, Vezina CM (2019). A Temporal and Spatial Map of Axons in the Developing Mouse Prostate. Histochem Cell Biol. 2019 Apr 11. PMID: 30976911; DOI: 10.1007/s00418-019-01784-6.
  6. Macoska JA, Wang ZY, Virta J, Zacharias N, Bjorling DE (2019). Inhibition of the CXCL12/CXCR4 Axis Prevents Peri-urethral Collagen Accumulation and Lower Urinary Tract Dysfunction In Vivo. The Prostate. 2019 May;79(7):757-767. PMID: 30811623; PMC Journal – In Process; DOI: 10.1002/pros.23781; NIHMS: 101632.
  7. Hao L, Thomas S, Greer T, Vezina CM, Bajpai S, Ashok A, De Marzo AM, Bieberich CJ, Li L, Ricke WA (2019). Quantitative Proteomic Analysis of a Genetically Induced Prostate Inflammation Mouse Model via Custom 4-plex DiLeu Isobaric Labeling (2019). Am J Physiol Renal Physiol. 2019 Apr 17. PMID: 30864837; DOI: 10.1152/ajprenal.00387.2018.
  8. Wegner KA, Mehta V, Johansson JA, Mueller BR, Keil KP, Abler LL, Marker PC, Taketa MM, Headon DJ, Vezina CM (2019). Edar is a Downstream Target of Beta-catenin and Drives Collagen Accumulation in the Mouse Prostate. Biol Open. 2019 Mar 18;8(3), pii:bio037945; PMID: 30745437; PMC6451354; DOI: 1242/bio.037945.
  9. Joseph DB, Chandrashekar AS, Abler LL, Chu L-F, Thomson JA, Vezina CM (2019). Epithelial DNA Methyltransferase-1 Regulates Cell Survival, Growth and Differentiation in Developing Prostate Buds. Dev Biol. 2019 Mar 15;447(2):157-169. PMID: 30659795; PMC6469356 [Available on 2020-03-15]; DOI: 1016/j.ydbio.2019.01.011; NIHMS1519785.
  10. Ricke WA, Bruskewitz RC, Liu TT (2019). Targeting a Fibrotic Bottleneck May Provide an Opening in the Treatment of LUTS. AJP-Renal. 2019 Mar 13; PMID: 30864837; PMC Journal – In Process; DOI:10.1152/ajprenal.00102.2019 [epub ahead of print].
  11. Joseph DB, Chanrashekar AS, Chu L-F, Thomson JA, Vezina CM (2019). A Folic Acid-Enriched Diet Attenuates Prostate Involution in Response to Androgen Deprivation. The Prostate. 2019 Feb;79(2):183-194. PMID: 30298636; PMC6420320; DOI: 1002/pros.23723.
  12. Lloyd GL, Ricke WA, McVary KT (2019). Inflammation, Voiding and BPH Progression. The Journal of Urology. 2019 Jan 25. PMID: 30694937; PMC Journal – In Process; DOI: 1097/JU.0000000000000049[Epub ahead of print].
  13. Liu TT, Ewald JA, Ricke EA, Bell R, Collins C, Ricke WA (2018). Modeling Human Prostate Cancer Progression in Vitro. Carcinogenesis. 2018 Dec 22. PMID: 30590461; PMC Journal – In Process; DOI: 1093/carcin/bgy185. [ePub ahead of print].
  14. Joseph DB, Strand DW, Vezina CM (2018). DNA Methylation in Development and Disease: An Overview for Prostate Researchers. Amer J Clin Exp Urol. 2018 Dec 20;6(6):197-218. PMID: 30697577; PMC6334199.
  15. Ma F, Liu F, Xu W, Li L. (2018). Surfactant and Chaotropic Agent Assisted Sequential Extraction/On-Pellet Digestion (SCAD) for Enhanced Proteomics. J Proteome Res. 2018 Aug 3;17(8):2744-2754. PMID: 29923408; PMC6171104; DOI: 10.1021/acs.jproteome.8b00197. Epub 2018 Jul 9.
  16. Hao L, Wang J, Page D, Asthana S, Zetterberg H, Carlsson C, Okonkwo OC, Li L (2018). Comparative Evaluation of MS-based Metabolomics Software and Its Application to Preclinical Alzheimer’s Disease. Sci Rep. 2018 Jun 18;8(1):9291.  PMID: 29915347; PMC6006240; DOI: 10.1038.s41598-018-27031-x.
  17. Chen Z, Yu Q, Hao L, Liu F, Johnson J, Tian Z, Kao WJ, Xu W, Li L. (2018). Site-specific Characterization and Quantitation of N-glycopeptides in PKM2 Knockout Breast Cancer Cells using DiLeu Isobaric Tags Enabled by Electron-transfer/Higher-energy Collision Dissociation (EThcD). Analyst. 2018 May 29;143(11):2508-2519. PMID: 29687791; PMC5975206 [Available on 2019-05-29]; DOI: 10.1039/c8an00216a.
  18. Henry GH, Malewska A, Joseph DB, Malladi VS, Lee J, Torrealba J, Mauck RJ, Gahan JC, Raj GV, Roehrborn CG, MacConmara MP, Reese JC, Hutchinson RC, Vezina CM, Strand DW (2018). A Cellular Anatomy of the Normal Adult Human Prostate and Prostatic Urethra. Cell Reports. 2018 Dec 18;25(12):3530-3542.e5. PMID: 30566875; PMC6411034; DOI: 1016/j.celrep.2019.11.086; NIHMS1517612.
  19. Hao L, Shi Y, Thomas S, Vezina C, Bajpai S, Ashok A, Bieberich CJ, Ricke WA, Li L (2018). Comprehensive Urinary Metabolomic Characterization of a Genetically induced Mouse Model of Prostatic Inflammation. Int J Mass Spectrom. 2018 Nov;434:185-192.PMC Journal – In Process; DOI: 1016/j.ijms.2018.09.017; NIHMS 1013142.
  20. Affas S, Schäfer FM, Algarrahi K, Cristofaro V, Sullivan MP, Yang X, Costa K,Sack B, Gharaee-Kermani M, Macoska JA, Gundogdu G, Seager C, Estrada CR Jr, Mauney JR (2018). Augmentation Cystoplasty of Diseased Porcine Bladders with Bi-Layer Silk Fibroin Grafts. Tissue Eng Part A. 2018 Oct 26. PMID: 30191762; PMC Journal – In Process; DOI: 1089/ten.TEA.2018.0113. [Epub ahead of print].
  21. Cunha GR, Vezina CM, Isaacson D, Ricke WA, Timms BG, Cao M, Franco O, Baskin LS (2018). Development of the Human Prostate. Differentiation. 2018 Sep-Oct;103:24-45. PMID: 30224091; PMC6234090; DOI: 1016/j.diff.2018.08.005. Epub 2018 Sep 4. Review.
  22. Hill WG, Zeidel ML, Bjorling DE, Vezina CM (2018). The Void Spot Assay: Recommendations on the Use of a Simple Micturition Assay for Mice. Amer J Physiol-Renal. 2018 Nov 1;315(5):F1422-1429. PMID: 30156116; PMC6293303; DOI: 1152/ajprenal.00350.2018.
  23. Shea MP, O’Leary KA, Wegner KA, Vezina CM, Schuler LA (2018). High Collagen Density Augments mTOR-dependent Cancer Stem Cells in ERα+ Mammary Carcinomas, and Increases mTOR-independent Lung Metastases. Cancer Lett. 2018 Oct 1;433:1-9. PMID: 29935374; PMC6064659; DOI: 1016/j.canlet.2018.06.025.
  24. Wegner KA, Abler LL, Oakes SR, Mehta GS, Ritter E, Hill WG, Zwaans BMM, Lamb LE, Wang Z, Bjorling DE, Ricke WA, Macoska J, Marker PC, Southard-Smith EM, Eliceiri KW, Vezina CM (2018). Void Spot Assay Procedural Optimization and Software for Rapid and Objective Quantification of Rodent Voiding Function, Including Overlapping Urine Spots. Amer J Physiol-Renal. 2018 Oct 1;315(4):F1067-1080. PMID: 29972322; PMC6230749; DOI: 1152/ajprenal.00245.2018. Epub 2018 Jul 4.
  25. Abler LL, Vezina CM (2018). Links Between Lower Urinary Tract Symptoms, Intermittent Hypoxia, and Diabetes: Causes or Cures? Respir Physiol Neurobiol. 2018 Oct;256:87-96. PMID: 28923778; PMC5857412 [Available on 2019-10-01]; DOI: 1016/j.resp.2017.09.009.
  26. Joseph DB, Chandrashekar AS, Abler LL, Chu LF, Thomson JA, Mendelsohn C, Vezina CM (2018). In Vivo Replacement of Damaged Bladder Urothelium by Wolffian Duct Epithelial Cells. Proc Natl Acad Sci USA. 2018 Aug 14;115(33):8394-8399. PMID: 30061411; PMC6099915; DOI: 1073/pnas.1802966115.
  27. Weaver SR, Fricke HP, Xie C, Lipinski RJ, Vezina CM, Charles JF, Hernandez LL (2018). Peripartum Fluoxetine Reduces Maternal Trabecular Bone After Weaning and Elevates Mammary Gland Serotonin and PTHrP. Endocrinology. 2018 Aug 1;159(8):2850-2862. PMID: 29893816; PMC6456925 [Available on 2019-09-08]; DOI: 1210/en.2018-00279.
  28. Ruetten H, Wegner KA, Romero MF, Wood MW, Marker PC, Strand DW, Colopy SA, Vezina CM (2018). Prostatic Collagen Architecture in Neutered and Intact Canines. Prostate. 2018 Aug;78(11):839-848. PMID: 29740846; PMC6356104 [Available on 2019-08-01]; DOI: 10.1002/pros.23641; ISSN 1097-0045; NIHMS1003000.
  29. Nicholson TM, Nguyen JL, Leverson GE, Taylor JA, Vom Saal FS, Wood RW, Ricke WA (2018). The Endocrine Disruptor Bisphenol-A is Implicated in Urinary Voiding Dysfunction in Male Mice. Am J Physiol Renal Physiol. 2018 Jul 18. PMID: 30019933; PMC6293302; DOI: 1152/ajprenal.00582.2017. [Epub ahead of print].
  30. Coriano CG, Liu F, Sievers CK, Liang M, Wang Y, Lim Y, Yu M, Xu W (2018). A Computational-Based Approach to Identify Estrogen Receptor Alpha/Beta Heterodimer Selective Ligands. Mol Pharmacol. 2018 Mar;93(3):197-207. Epub 2018/01/04. PMID: 29295894; PMC5801554; DOI: 10.1124/mol.117.108696.
  31. Patalano-Salsman S, Rodriguez-Nieves J, Colaneri C, Cotellessa J, Almanza D, Zhilin-Roth A, Riley T, Macoska J (2018). CXCL12/CXCR4-Mediated Procollagen Secretion Is Coupled to Cullin-RING Ubiqutin Ligase Activation. Sci Rep .2018 Feb 22;8(1):3499. PMID: 29472636; PMC5823879; DOI: 1038/s41598-018-21506-7.
  32. Ritter E, Wang Z, Vezina CM, Bjorling DE, Southard-Smith EM (2017). Serotonin Receptor 5-HT3A Affects Development of Bladder Innervation and Urinary Bladder Function. Front Neurosci. 2017 Dec 12;11:690. PMID: 29311772; PMC5732969; DOI: 3389/fnins.2017.00690.
  33. Wegner KA, Cadena MT, Trevena R, Turco AE, Gottschalk A, Halberg RB, Guo J, McMahon JA, McMahon AP, Vezina CM (2017). An Immunohistochemical Identification Key for Cell Types in Adult Mouse Prostatic and Urethral Tissue Sections. PLoS One. 2017 Nov 16;12(11):e0188413. PMID: 29145476; PMC5690684; DOI: 1371/journal.pone.0188413.
  34. Liu F, Ma F, Wang Y, Hao L, Zeng H, Jia C, Wang Y, Liu P, Ong IM, Li B, Chen G, Jiang J, Gong S, Li L, Xu W (2017). PKM2 Methylation by CARM1 Activates Aerobic Glycolysis to Promote Tumorigenesis. Nat Cell Biol. 2017 Nov;19(11):1358-70. Epub 2017/10/24. PMID: 29058718; PMC5683091; DOI: 1038/ncb3630.
  35. McLean DT, Strand DW, Ricke WA (2017). Prostate Cancer Xenografts and Hormone Induced Prostate Carcinogenesis. Differentiation. 2017 Sep-Oct;97:23-32. PMID: 28923776; PMC Journal – In Process; ISSN 1432-0436; DOI: 1016/j.diff.2017.08.005.
  36. Keikhosravi A, Liu Y, Drifka C, Woo KM, Verma A, Oldenbourg R, Eliceiri KW (2017). Quantification of Collagen Organization in Histopathology Samples Using Liquid Crystal Based Polarization Microscopy. Biomed Opt Express. 2017 Aug 29;8(9):4243-56. Epub 2017/10/03. PMID: 28966862; PMC5611938; DOI: 1364/BOE.8.004243.
  37. Liu Y, Keikhosravi A, Mehta GS, Drifka CR, Eliceiri KW (2017). Methods for Quantifying Fibrillar Collagen Alignment. Methods Mol Biol. 2017;1627:429-51. Epub 2017/08/25. PMID: 28836218; PMC6343484; DOI: 1007/978-1-4939-7113-8_28.
  38. McAuley E, Mustafi D, Simons B, Valek R, Zamora M, Markiewicz E, Lamperis S, Williams A, Roman B, Vezina CM, Karczmar G, Oto A, Vander Griend D (2017). Magnetic Resonance Imaging and Molecular Characterization of a Hormone-Mediated Murine Model of Prostate Enlargement and Bladder Outlet Obstruction. Amer J Pathol. 2017 Aug 18;187:2378-2387. PMID: 28823870; PMC5762949; DOI: 1016/j.ajpath.2017.07.014.
  39. Wegner KA, Keikhosravi A, Eliceiri KW, Vezina CM (2017). Fluorescence of Picrosirius Red Multiplexed With Immunohistochemistry for the Quantitative Assessment of Collagen in Tissue Sections. J Histochem Cytochem. 2017 Aug;65(8):479-90. Epub 2017/07/12. PMID: 28692327; PMC5533271; DOI: 1369/0022155417718541.
  40. Strand DW, Costa DN, Francis F, Ricke WA, Roehrborn CG (2017). Targeting Phenotypic Heterogeneity in Benign Prostatic Hyperplasia. Differentiation. 2017 Jul-Aug;96:49-61. PMID: 28800482; PMC566834; DOI: 1016/j.diff.2017.07.005. Epub 2017 Aug 4. Review.
  41. Shishkova E, Zeng H, Liu F, Kwiecien NW, Hebert AS, Coon JJ, Xu W (2017). Global Mapping of CARM1 Substrates Defines Enzyme Specificity and Substrate Recognition. Nat Commun. 2017 May 24;8:15571. Epub 2017/05/26. PMID: 28537268; PMC5458078; DOI: 1038/ncomms15571.
  42. Le B, Powers GL, Tam YT, Schumacher N, Malinowski RL, Steinke L, Kwon G, Marker PC (2017). Multi-drug Loaded Micelles Delivering Chemotherapy and Targeted Therapies Directed Against HSP90 and the PI3K/AKT/mTOR Pathway in Prostate Cancer. PLoS One.  2017 Mar 28;12(3):e0174658. PMID: 28350865; PMC5370140; DOI: 1371/journal/pone.0174658.
  43. Mulligan WA, Wegner KA, Keil KP, Mehta V, Taketo M, Vezina CM (2017). Beta-Catenin and Estrogen Signaling Collaborate to Drive Cyclin D1 Expression in Developing Mouse Prostate. Differentiation. 2017 Jan-Feb;93:66-71. PMID: 27918915; PMC5285411; DOI: 1016/j.diff.2016.11.002. Epub 2016 Dec 2.
  44. Zeng H, Lu Li, Chan NT, Hoswill M, Ahlquist P, Zhong X, Xu W (2016). Systematic Identification of Ctr9 Regulome in ER-Alpha-Positive Breast Cancer. BMC Genomics. 2016 Nov 9;17(1):902. PMID: 27829357; PMC5103509; DOI: 1186/s12864-016-3248-3.
  45. Brinkman A, Chen G, Wang Y, Hedman CJ, Sherer N, Havighurst TC, Xu W (2016). Aminoflavone-loaded EGFR-targeted Unimolecular Micelle Nanoparticles Exhibit Anti-Cancer Effects in Triple-Negative Breast Cancer. Biomaterials. 2016 Sep;101:20-31. PMID: 27267625; PMC5030715; DOI: 1016/j.biomaterials.2016.05.041.
  46. Drifka CR, Leoffler AG, Mathewson K, Mehta G, Keikhosravi A, Liu Y, Lemanik S, Ricke WA, Weber SM, Kao WJ, Eliceiri KW (2016). Comparison of Picrosirius Red Staining with Second Harmonic Generation Imaging for the Quantification of Clinically Relevant Collagen Fiber Features in Histopathology Samples. J Histochem Cytochem. 2016 Sep 64(9):519-29. PMID: 27449741; PMC5006137; DOI: 1369/0022155416659249. Epub 2016 Jul 22.
  47. Liu J-T, Do TJ, Simmons CJ, Lynch JC, Gu W, Ma Z-X, Xu W, Tang W (2016). Total Synthesis of Diptoindonesin G and its Analogues as Selective Modulators of Estrogen Receptors. Organic & Biomolecular Chemistry. 2016 Sept 12;14(38):8927-8930. PMID: 27714255; PMC Journal – In Process; DOI: 1039/c6ob01657j.
  48. Hao L, Greer T, Page D, Shi Y, Vezina CM, Macoska JA, Marker PC, Bjorling DE, Bushman W, Ricke WA, Li L (2016). In-Depth Characterization and Validation of Human Urine Metabolomes Reveal Novel Metabolic Signatures of Lower Urinary Tract Symptoms. Sci Rep. 2016 Aug 9(6):30869. PMID: 27502322; PMC4977550; DOI: 1038/srep30869.
  49. Rodriguez-Nieves JA, Patalano SC, Almanza D, Gharaee-Kermani M, Macoska JA (2016). CXCL12/CXCR4 Axis Activation Mediates Prostate Myofibroblast Phenoconversion Through Non-Canonical EGFR/MEK/ERK Signaling. PLoS One. 2016 Jul 19;11(7):e0159490. PMID: 27434301; PMC4951124; DOI: 1371/journal/pone.0159490. eCollection 2016.
  50. Jeong CH, Gao L, Dettro T, Wagner ED, Ricke WA, Plewa JM, Flaws JA (2016). Monohaloacetic Acid Drinking Water Disinfection By-Products Inhibit Follicle Growth and Steroidogenesis in Mouse Ovarian Antral Follicles In Vitro. Reprod Toxicol. 2016 Jul;62:71-6. PMID: 27151372; PMC4905796; DOI: 1016/j.reprotox.2016.04.028. Epub 2016 May 2.
  51. Gharaee-Kermani M, Moore BB, Macoska JA (2016). Resveratrol-Mediated Repression and Reversion of Prostatic Myofibroblast Phenoconversion. PLoS One. 2016 Jul 1;11(7):e0158357. PMID: 27367854; PMC4930165; DOI: 1371/journal.pone.0158357. eCollection 2016
  52. Liu TT, Grubisha MJ, Frahm KA, Wendell SG, Liu J, Ricke WA, Auchus RJ, DeFranco DB (2016). Opposing Effects of Cyclooxygenase-2 (COX-2) on Estrogen Receptor Beta (Erbeta) Response to 5alpha-reductase Inhibition in Prostate Epithelial Cells. J Biol Chem. 2016 Jul 8;291(28):14747-60. PMID: 27226548; PMC4938192; DOI: 1074/jbc.M115.711515. Epub 2016 May 13.
  53. Bauman TM, Vezina CM, Ricke EA, Halberg RB, Huang W, Peterson RE, Ricke WA (2016). Expression and Colocalization of Beta-Catenin and Lymphoid Enhancing Factor-1 in Prostate Cancer Progression. Hum Pathol. 2016 May;51:124-33. Epub 2016 Jan 19. PMID: 2706770; PMC4830919; DOI: 1016/j.humpath.2015..12.024.
  54. Ricke WA, Lee CW, Clapper TR, Schneider AJ, Moore RW, Keil KP, Abler LL, Wynder JL, López Alvarado A, Beaubrun I, Vo J, Bauman TM, Ricke EA, Peterson RE, and Vezina CM (2015). In uteroand Lactational TCDD Exposure Increases Susceptibility to Lower Urinary Tract Dysfunction in Adulthood. Toxicol Sci. 2016 Apr;150(2):429-40. PMID: 26865671; PMC4900134; DOI: 1093/toxci/kfw009. Epub 2016 Feb 9.
  55. Thomas S, Hao L, Ricke WA, Li L (2016). Biomarker Discovery in Mass Spectrometry-Based Urinary Proteomics. Proteomics Clin Appl. 2016 Apr;10(4):358-70. PMID: 26703953; PMC4888976; DOI: 1002/prca.201500102. Epub 2016 Feb 11. Review.
  56. Bauman TM, Ricke EA, Drew SA, Huang W, Ricke WA (2016). Quantitation of Protein Expression and Co-localization Using Multiplexed Immuno-histochemical Staining and Multispectral Imaging. J Vis Exp. 2016 Apr 8(110):53837. PMID: 27167094; PMC4913774; DOI: 3791/53837.
  57. Zeng H, Xu W (2016). Gene Expression Profiling of Ctr9-regulated Transcriptome in ERalpha-positive Breast Cancer. Genomics data. 2016 Mar;7:103-104. PMID: 26981377; PMC4778656; DOI: 101/j.gdata.2015.12.006.
  58. Keil KP, Abler LL, Altmann HM, Bushman W, Marker PC, Li L, Ricke WA, Bjorling DE, Vezina CM (2016). Influence of Animal Husbandry Practices on Void Spot Assay Outcomes in C57BL/6J Male Mice. Neurourol Urodyn. 2016 Feb;35(2):192-8. PMID: 25394276; PMC4428995; DOI: 1002/nau.22692. Epub 2014 Nov 12.
  59. Bauman TM, Becka AJ, Sehgal PD, Huang W, Ricke WA (2015). SIGIRR/TIR8, an Important Regulator of TLR4 and IL-1R-mediated NF-kB Activation, Predicts Biochemical Recurrence after Prostatectomy in Low-Grade Prostate Carcinomas. Hum Pathol. 2015 Nov;46(11):1744-51. PMID: 26344417; PMC4661098; DOI: 1016/j.humpath.2015.07.015. Epub 2015 Jul 29.
  60. Gamat M, Malinowski RL, Parkhurst LJ, Steinke LM, Marker PC (2015). Ornithine Decarboxylase Activity is Required for Prostatic Budding in the Developing Mouse. PLoS One. 2015 Oct 1;10(10): e0139522. PMID: 26426536; PMC4534462; DOI: 1371/journal.pone.0139522.
  61. Wynder JL, Nicholson TM, DeFranco DB, Ricke WA (2015). Estrogens and Male Lower Urinary Tract Dysfunction. Curr Urol Rep. 2015 Sep;16(9):6
  62. Greer T, Hao L, Nechyporenko A, Lee S, Vezina CM, Ricke WA, Marker PC, Bjorling DE, Bushman W, Li L (2015). Custom 4-Plex DiLeu Isobaric Labels Enable Relative Quantification of Urinary Proteins in Men with Lower Urinary Tract Symptoms (LUTS). PLoS One. 2015 Aug 12;10(8):e0135415. PMID: 26267142; PMC4534462; DOI: 1371/journal.pone.0135415. eCollection 2015.
  63. Begley LA, Kasina S, Shah RB, Macoska JA (2015). Signaling Mechanisms Coupled to CXCL12/CXCR4-mediated cellular Proliferation are PTEN-dependent. Am J Clin Exp Urol. 2015 Aug 8;3(2):91-9. eCollection 2015. PMID: 26309898; PMC4539110.
  64. Bauman TM, Ewald JA, Huang W, Ricke WA (2015). CD147 Expression Predicts Biochemical Recurrence after Prostatectomy Independent of Histological and Pathologic Features. BMC Cancer. 2015 Jul 25;15:549. PMID: 26209327; PMC4514016; DOI: 1186/s12885-015-1559-4.
  65. Bjorling DE, Wang Z, Vezina CM, Ricke WA, Keil KP, Yu W, Guo L, Zeidel ML, Hill WG (2015). Evaluation of Voiding Assays in Mice: Impact of Genetic Strains and Sex. Amer J Physiol-Renal. 2015 Jun 15;308(12):F1369-78. PMID: 25904700; PMC4469884; DOI: 1152/ajprenal.00072.2015. Epub 2015 Apr 22.
  66. Keil KP, Abler LL, Altmann HM, Wang ZY, Wang P, Ricke WA, Bjorling DE, Vezina CM (2015). Impact of a Folic Acid-Enriched Diet on Prostate and Urinary Function in Mice Treated with Testosterone and Estradiol. Amer J Physiol-Renal. 2015 Jun 15;308(12):F1431-43. PMID: 25855514; PMC4469891; DOI 1152/ajprenal.00674.2014. Epub 2015 Apr 8.
  67. Theberge AB, Yu J, Young EW, Ricke WA, Bushman W, Beebe DJ (2015). Microfluidic Multiculture Assay to Analyze Biomolecular Signaling in Angiogenesis. Anal Chem. 2015 Mar 17;87(6):3239-46. PMID: 25719435; PMC4405103; DOI: 1021/ac503700f. Epub 2015 Feb 26.
  68. Moses MA, Henry EC, Ricke WA, Gasiewicz TA (2015). The Heat Shock Protein 90 Inhibitor, (-)-Epigallocatechin Gallate, Has Anticancer Activity in a Novel Human Prostate Cancer Progression Model. Cancer Prev Res (Phila). 2015 Mar;8(3):249-57. PMID: 25604133; PMC4355219; DOI: 1158/1940-6207. CAPR-14-0224. Epub 2015 Jan 20.
  69. Nicholson TM, Moses MA, Uchtmann KS, Keil KP, Bjorling DE, Vezina CM, Wood RW, Ricke WA (2015). Estrogen Receptor-Alpha is a Key Mediator and Therapeutic Target for Bladder Complications of Benign Prostatic Hyperplasia. J Urol. 2015 Feb;193(2):722-729. PMID: 25167991; PMC4305478; DOI: 1016/j.juro.2014.08.093.
  70. Powers GL, Hammer KDP, Domenech M, Frantskevich K, Malinowski RL, Bushman W, Beebe DJ, Marker PC (2015). Phosphodiesterase 4D Inhibitors Limit Prostate Cancer Growth Potential. Molecular Cancer Research. 2015 Jan;13(1):149-60. PMID: 25149359; PMC4312503; DOI: 1158/1541-7786.MCR-14-0110.
  71. Bauman TM, Vezina CM, Huang W, Marker PC, Peterson RE, Ricke WA (2014). Beta-Catenin is Elevated in Human Benign Prostatic Hyperplasia Specimens Compared to Histologically Normal Prostate Tissue. Am J Clin Exp Urol. 2014 Dec 25;2(4):313-22. eCollection 2014. PMID: 25606577. PMC4297327.
  72. Bauman TM, Nicholson TM, Abler LL, Eliceiri KW, Huang W, Vezina CM, Ricke WA (2014). Characterization of Fibrillar Collagens and Extracellular Matrix of Glandular Benign Prostatic Hyperplasia Nodules. PLoS One. 2014 Oct 2;9(10):e109102. PMID: 25275645. PMC4183548; DOI: 1371/journal/pone.0109102. eCollection 2014 9:e109102.
  73. Gharaee-Kermani M, Mehra R, Robinson DR, Wei JT, Macoska JA (2014). Complex Cellular Composition of Solitary Fibrous Tumor of the Prostate. Am J Pathol. 2014 Mar;184(3):732-9. PMID: 24434011; PMC3936322; DOI: 10.1016/j.ajpath.2013.11.024. Epub 2014 Jan 13.

BOOK CHAPTERS

  1. Ricke WA, Timms BG, vom Saal FS (2018). PROSTATE STRUCTURE. In: Skinner M, editor. Encyclopedia of Reproduction. 2 ed: Academic Press; 2018.
  2. Ricke W, Williams K, Wynder J, Palapattu G, Wang YZ, Cunha G (2017). Hormonal carcinogenesis: Role of estrogens. In: Coleman WB, Tsongalis GJ, eds. The Molecular Basis of Human Cancer. 2 ed: Humana Press; 2017:1-12.
  3. Ricke WA, Williams K, Wynder J, Palapattu, G, Wang Y, Cunha GR (2016). “Hormonal Carcinogenesis: The Role of Estrogens” In: The molecular basis of cancer 2nd, 2016:307-322.
  4. Macoska J.A., Kasina S., Campeau L., Andersson KE (2014). The Biology of Aging and the Development of Lower Urinary Tract Dysfunction and Disease. In: Griebling T. (eds) Geriatric Urology. Springer, New York, NY

PUBLICATIONS – OTHER

  1. Bjorling, DE (2018). Keys to an Outstanding Career Development Plan. E-edcuation course, module 1 of 4 in the course, “Writing a Successful Career Development Award Application”, posted in AUA University at https://auau.auanet.org/content/writing-successful-career-development-award-application-2018#group-tabs-node-course-default1
  2. Vezina, CM (2018). Keys to an Outstanding Career Development Plan. E-education course, module 1 of 4 in the course, “Writing a Successful Career Development Award Application,” posted in AUA University at https://auau.auanet.org/content/writing-successful-career-development-award-application-2018#group-tabs-node-course-default1
  3. Ricke WA, Bushman W (2016). Stratifying the Care of BPH: from Bench to Bedside and Back. AUA NEWS. Vol 21. Linthicum, MD 21090: American Urological Association; 2016:23-25.
  4. National Urology Research Agenda (NURA) publication, “Research Infrastructure”, David Jarrard, MD; Aria Olumi, MD; William Ricke, PhD; Hunter Wessels, MD.IN PRESS.
  5. Ricke WA, Williams K, Wynder J, Palapattu, G, Wang Y, Cunha GR (2016). “Hormonal Carcinogenesis: The Role of Estrogens” In: The molecular basis of cancer 2nd, 2016:307-322.
  6. Ricke WA (2014-present), Contributor to ‘monthly accomplishments’. In: University of Wisconsin’s Department of Urology Newsletter.

ABSTRACTS

  1. Ricke WA, Vellky J (2018). “Post-transcriptional Regulation of Androgen Receptor by DDX3 as a Mechanism for CRPC.” Society for Basic Urologic Research (SBUR) Fall Symposium, Rancho Mirage, CA, November 2018.
  2. Cadena MT, Turco AE, Romero PZ, Holmes HL, Romero MF, Tykocki N, Vezina CM (2018). “Mouse Prostatic Neuroendocrine Cells Mediate Smooth Muscle Contraction.” Society for Basic Urologic Research (SBUR) Fall Symposium, Rancho Mirage, CA, November 2018.
  3. Ruetten H, Zhang HL, Wegner KA, Wang P, Wang Z, Bjorling DE, Ricke WA, Marker PC, Vezina CM (2018). “Does Size Matter?: Reduced Prostate Size Alters Urinary Function in Male Mice.” Society for Basic Urologic Research (SBUR) Fall Symposium, Rancho Mirage, CA, November 2018.
  4. Wegner KA, Guo J, McMahon JA, McMahon AP, Vezina CM (2018). “Characterization of Srd5a2creErt2 Expression in the Mouse Prostate: A Potential Source of Stromal Progenitors.” Society for Basic Urologic Research (SBUR) Fall Symposium, Rancho Mirage, CA, November 2018.
  5. Unterberger CJ, Wegner KA, Malinowski RL, Vezina CM, Swanson SM, Marker PC (2018). “Role of Growth Hormone in Prostate Cancer Progression.” Society for Basic Urologic Research (SBUR) Fall Symposium, Rancho Mirage, CA, November 2018.
  6. Henry GH, Malewska A, Joseph DB, Malladi V, Lee J, Torrealba J, Mauck R, Gahan J, Raj G, Roehrborn C, Hon G, MacConmara M, Reese J, Hutchinson R, Vezina CM, Strand D (2018). “Single Cell RNA Sequencing of the Normal Human Prostate Reveals Identity of Novel Stromal and Epithelial Cell Types.” Society for Basic Urologic Research (SBUR) Fall Symposium, Rancho Mirage, CA, November 2018.
  7. Joseph DB, Chandrashekar AS, Abler LL, Chu L-F, Thomson JA, Vezina CM (2018). “Epithelial Dnmt1Regulates Prostate Bud Formation and Differentiation by Maintaining Survival of Early Prostate Progenitors”. Society for Basic Urologic Research (SBUR) Fall Symposium, Rancho Mirage, CA, November 2018.
  8. Sandhu S, Joseph DB, Strand DW, Vezina CM (2018). “Immunohistochemical Comparison of Novel Epithelial and Stromal Cell Types in the Human and Mouse Prostate”. Society for Basic Urologic Research (SBUR) Fall Symposium, Rancho Mirage, CA, November 2018.
  9. Ruetten H, Zhang HL, Wegner KA, Wang P, Wang Z, Bjorling DE, Ricke WA, Marker PC, Vezina CM (2018). “Does Size Matter?: Reduced Prostate Size Causes Urinary Dysfunction in Male Mice.” American College of Veterinary Pathology Annual Meeting, Washington, DC, November 2018.
  10. Romero PZ, Holmes HL, Cadena M, Vezina CM, Romero MF. “Nbce1 in the Kidney and Lower Urogenital Tract.” NIDDK KUH Summer Undergraduate Research Conference,Boston, MA, August 1-3, 2018.
  11. Zhang HL, Ruetten H, Wegner KA, Vezina CM (2018). “Does Size Matter?: Reduced Prostate Size Causes Urinary Dysfunction in Male Mice”. 3rd Annual Symposium for the Summer Program in Undergraduate Urologic Research (SPUUR), Aug 12, 2018.
  12. Mueller B, Wegner KA, Vezina CM (2018).  “Prostate Extracellular Matrix Morphology Associates with Lower Urinary Tract Dysfunction in Male Mice”. 3rd Annual Symposium for the Summer Program in Undergraduate Urologic Research (SPUUR), Aug 12, 2018.
  13. Ricke WA, Li L, Thomas S (2018). “Collagenase Digestion Deepens Coverage of Extracellular Matrix in Urinary Proteomics”. Wisconsin Human Proteomics Symposium, Madison, WI, August 2018.
  14. Sandhu S, Joseph DB, Strand DW, Vezina CM (2018). “Immunohistochemical Comparison of Novel Epithelial and Stromal Cell Types in the Human and Mouse Prostate.” 3rd Annual Symposium for the Summer Program in Undergraduate Urologic Research (SPUUR), Aug 12, 2018.
  15. Romero PZ, Holmes HL, Cadena M, Vezina CM, Romero MF (2018). “Nbce1 in the Kidney and Lower Urogenital Tract.” 3rd Annual Symposium for the Summer Program in Undergraduate Urologic Research (SPUUR), Aug 12, 2018.
  16. Ruetten H, Wegner K, Colopy S, Zhang H, Sandhu S, Romero M, Vezina CM (2018). “Impact of Age and Castration on Canine Prostate Collagen Organization.” Abstract for poster or oral presentation,2018 Therio Conference; Milwaukee, WI, August 2018.
  17. Sack B, Piper M, Cotellessa J, Doyle C, Gharaee-Kermani M, Avery A, Mahmood F, Cristofaro V, Sullivan M, Macoska JA, Adam R (2018). “Expression Profiling of Experimental Neurogenic Bladder Reveals Decreased b3-Adrenergic Receptor Expression That Can Be Reversed By Inoside Treatment.” MP56-07.  J. Urol. Vol. 199, No. 4S, Supplement, Sunday, May 20, 2018.
  18. Ricke WA, Jeong CH, Liu TT (2018). “The Impact of Age on the Lower Urinary Tract of Mice”.Society for Basic Urologic Research (SBUR) Spring Symposium, San Francisco, CA, May 2018.
  19. Sack BS, Piper M, Cotellessa JF, Doyle C, Gharaee-Kermani M, Avery A, Mahmood F, Cristofaro V, Sullivan MP, Macoska JA, Adam RM (2018). “Expression Profiling of Experimental Neurogenic Bladder Reveals Decreased beta 3-AR Expression that can be Reversedy by Inoside Treatment.” American Urological Association (AUA) Annual Meeting, Boston, MA May 12-16, 2018.
  20. Ricke WA, Ricke EA, Walker I, Jeong CH, Thomas S, Liu TT (2018). “Altered steroidogenesis on Estrogen Receptor Activation in Benign Prostatic Hyperplasia”. University of Wisconsin-Madison/UMASS Boston George M. O’Brien Center Spring Symposium,Madison, WI, April 2018.
  21. Zhang H, Vezina CM (2018). “Castration Reduces Duration and Increases Frequency of Urination.” University of Wisconsin Undergraduate Research Symposium, Madison, WI, April 2018.
  22. Li L, Ricke WA, Steinke L, Hyman S, Delaney K, Hao L, Thomas S (2018). “Proteomics by Mass Spectrometry for Molecular Insights into Lower Urinary Tract Dysfunction due to Endocrine Disruption in Mice.” University of Wisconsin-Madison/UMASS Boston George M. O’Brien Center Spring Symposium,Madison, WI, April 2018.
  23. Macoska JA, Ricke WA, Uchtmann KS (2018). “Prostate Collagen Deposition is Associated with the Clinical Progression of LUTD and LUTS Among MTOPS Trial Participants.” University of Wisconsin-Madison/UMASS Boston George M. O’Brien Center Spring Symposium,Madison, WI, April 2018.
  24. Ricke WA, Vellky J (2018). “Post-transcriptional Regulation of Androgen Receptor by DDX3 in Prostate Cancer Progression.” University of Wisconsin-Madison/UMASS Boston George M. O’Brien Center Spring Symposium,Madison, WI, April 2018.
  25. Ricke WA, Vellky J (2018). “Post-transcriptional Regulation of Androgen Receptor by DDX3 in Prostate Cancer Progression.” American Association for Cancer Research (AACR), Chicago, IL, April 2018.
  26. Ricke WA, Vellky J, Cunningham K, McLean D (2018). “Androgen Receptor Expression Through an FGF5 and YAP1 Driven Mechanism.” American Association for Cancer Research (AACR), Chicago, IL, April 2018. Ruetten H, Wegner K, Zhang H, Sandhu S, Romero M, Wood M, Marker PC, Strand DW, Colopy S, Vezina CM (2018). “Impact of Age and Castration on Canine Prostate Collagen Organization.” Abstract for poster and/or oral presentation, 6th Annual University of Wisconsin-Madison School of Veterinary Medicine-Phi Zeta Research Day; Madison, WI, April 2018.
  27. Li L, Ricke WA, Steinke L, Hyman S, Delaney K, Hao L, Thomas S (2018). “Proteomics by Mass Spectrometry for Molecular Insights into Lower Urinary Tract Dysfunction due to Endocrine Disruption in Mice”. 7thAnnual International Meeting of Young Environmental Scientists of the Society of Environmental Toxicology and Chemistry, Madison, WI, March 2018.
  28. Sack BS, Piper M, Cotellessa JF, Doyle C, Gharaee-Kermani M, Avery A, Mahmood F, Cristofaro V, Sullivan M, Macoska JA, Adam RM (2018). “Expression Profiling of Experimental Neurogenic Bladder Reveals Decreased β3-Adrenergic Receptor Expression that can be Reversed by Inosine Treatment”. Society for Urodynamics and Female Urology (SUFU) Annual Meeting, February 27 – March 3, 2018, Austin, TX.
  29. Wegner KA, Turco A, Wang P, Bjorling DE, Peterson RE, Vezina CM (2018). “In Utero and Lactational (IUL) TCDD Exposure Causes Lower Urinary Dysfunction in Adult Male C57BL/6J Mice.” Abstract for poster presentation, Society of Toxicology Annual Meeting, San Antonio, TX, March 2018.
  30. Ruetten H, Wegner K, Joseph D, Colopy S, Sullivan R, Vezina CM (2017). “Collagen Architecture of Canine and Murine Prostate: Impact of Age and Androgen Deprivation.” Abstract for poster presentation. Society for Basic Urologic Research (SBUR) 2017 Fall Symposium, Tampa, FL, November 2017.
  31. Li L, Ricke WA, Marker PC, Frost D, Hao L, Thomas S (2017). “A Proteomic Fingerprint of Hormone-Induced Lower Urinary Tract Dysfunction in Mice.” Society for Basic Urologic Research (SBUR) 2017 Fall Symposium, Tampa, FL, November 2017.
  32. Ricke WA, Ricke EA, Jeong CH, Liu TT (2017). “The Impact of Altered Steroidogenesis on Estrogen Receptor Activation in Benign Prostatic Hyperplasia Progression.” Society for Basic Urologic Research (SBUR) 2017 Fall Symposium, Tampa, FL, November 2017.
  33. Ricke WA, Vellky J (2017). “Hormonal Modulation of DDX3 and its Implications for Translational Regulation in Prostate Cancer.” Society for Basic Urologic Research (SBUR) 2017 Fall Symposium, Tampa, FL, November 2017
  34. Wegner KA, Guo J, McMahon JA, Maeda N, Wang P, Bjorling DE, Marker PC, McMahon AP, Vezina CM (2017). “Pro-fibrotic Signaling in Prostate Stroma Increases Prostate Collagen Fiber Density and Disrupts Normal Urinary Function in Male Mice.” Abstract for poster presentation, Society for Basic Urologic Research (SBUR) 2017 Fall Symposium, Tampa, FL, November 2017.
  35. Ruetten H, Colopy S, Sullivan R, Wegner K, Chandraskekar A, Vezina CM (2017). “Collagen Architecture of the Prostate in Neutered and Intact Canines.” Abstract for poster presentation, American College of Veterinary Pathologists (ACVP) & American Society for Veterinary Clinical Pathology (ASVCP) Concurrent Annual Meeting, Vacouver, British Columbia, Canada, November 2017.
  36. Li L, Ricke WA, Marker PC, Frost D, Hao L, Thomas S (2017). “A Proteomic Fingerprint of Hormone-Induced Lower Urinary Tract Dysfunction in Mice.” American Society for Mass Spectrometry, Indianapolis, IN, June 2017.
  37. Patalano-Salsman S, Rodriguez-Nieves JA, Almanza D, Avery A, Judell-Halfpenney A, Riley T, Macoska JA (2017). “CXCL12-CXCR4 Axis Activation Promotes COP II Vesicle-Mediated Secretion of Collagen by Prostate Myofibroblasts.” MP17-09. J. Urol. Vol. 197, No. 4S, Supplement,Friday, May 12, 2017.
  38. Gharaee-Kermani M, Macoska JA (2017). “TH2 Cytokines Promote Myofibroblast Phenoconversion and Prostatic Fibrosis.” J. Urol. Vol. 197, No. 4S, Supplement,Friday, May 12, 2017.
  39. Ricke WA, Macoska JA, James TT, Wyndner JL, Walker I, Liu TT (2017). “The Identification of Estrogen Receptor Gene Networks in Benign Prostatic Hyperplasia.” American Urological Association (AUA), Boston, MA, May 2017.
  40. Ricke WA, Macoska JA, James TT, Wyndner JL, Walker I, Liu TT (2017). “The Identification of Estrogen Receptor Gene Networks in Benign Prostatic Hyperplasia.” University of Wisconsin-Madison/UMASS Boston George M. O’Brien Center Spring Symposium: “Steroid Hormone Pathways and Mechanisms of Action in Benign Urologic Disease”, Madison, WI, May 2017.
  41. Macoska J (2017). “Role of G-Protein Coupled Receptors in Lower Urinary Tract Fibrosis.”   University of Wisconsin-Madison/UMASS Boston George M. O’Brien Center Spring Symposium: “Steroid Hormone Pathways and Mechanisms of Action in Benign Urologic Disease”, Madison, WI, May 2017.
  42. Li L, Ricke WA, Marker PC, Frost D, Hao L, Thomas S (2017). “A Proteomic Fingerprint of Hormone-Induced Lower Urinary Tract Dysfunction in Mice.” University of Wisconsin-Madison/UMASS Boston George M. O’Brien Center Spring Symposium: “Steroid Hormone Pathways and Mechanisms of Action in Benign Urologic Disease”, Madison, WI, May 2017.
  43. Ricke WA, Timms BG, Vom Saal FS, Achenreiner A, John LM, Uchtmann KS (2017). “Fetal Bisphenol A Exposure Alters Urethra Morphology and Collagen Content of One Year-Old Rats: Findings from the NIEHS/FDA CLARITY-BPA Research Program.” University of Wisconsin-Madison/UMASS Boston George M. O’Brien Center Spring Symposium: “Steroid Hormone Pathways and Mechanisms of Action in Benign Urologic Disease”, Madison, WI, May 2017.
  44. Vom Saal FS, Taylor J, Stahlhut R, Timms BG, Uchtmann KS, Ricke WA (2017). “Fetal Bisphenol A Exposure Alters Body Weight and Male Urogenital Tract Morphology At Birth: Findings From the NIEHS/FDA CLARITY Research Program.” University of Wisconsin-Madison/UMASS Boston George M. O’Brien Center Spring Symposium: “Steroid Hormone Pathways and Mechanisms of Action in Benign Urologic Disease”, Madison, WI, May 2017.
  45. Bathke K, Trevena RL, Cadena MT, Wegner KA, Turco AE, Vezina CM (2017). “Classification of Gli1 Expressing Cell Lineages Within Mouse Prostate.” Abstract for poster presentation, University of Wisconsin-Madison/UMASS Boston George M. O’Brien Center Spring Symposium: “Steroid Hormone Pathways and Mechanisms of Action in Benign Urologic Disease”, Madison, WI, May 2017.
  46. Shea MP, Wegner KA, O’Leary KA, Schuler LA (2017). “Collagen Density and mTOR Inhibition Alter Cancer Stemness and Plasticity of ER+ Mammary Carcinomas.” Abstract for poster presentation, University of Wisconsin-Madison/UMASS Boston George M. O’Brien Center Spring Symposium: “Steroid Hormone Pathways and Mechanisms of Action in Benign Urologic Disease”, Madison, WI, May 2017.
  47. Wegner KA, Keil KP, Wang Z, Wang P, Bjorling DE, Vezina CM (2017). “Genetic Background Influences Susceptibility of Male Mice to Hormone-induced Urinary Dysfunction.” Abstract for poster presentation, University of Wisconsin-Madison/UMASS Boston George M. O’Brien Center Spring Symposium: “Steroid Hormone Pathways and Mechanisms of Action in Benign Urologic Disease”, Madison, WI, May 2017.
  48. Ricke WA, Vellky J, McLean D (2017). “Androgen Regulation of Fibroblast Growth Factor 5 In Prostate Cancer.” Gordon Research Conference, Newry, Maine, August 2017.
  49. Ricke WA, Vellky J, McLean D (2017). “Androgen Regulation of Fibroblast Growth Factor 5 in Prostate Cancer.” Society for Basic Urologic Research (SBUR), Boston, MA, May 2017.
  50. Wynder, J (2017). “Bisphenol-A Induces Lower Urinary Tract Dysfunction in Adult Male Mice”. University of Wisconsin-Madison Molecular and Environmental Toxicology Center Annual Retreat, Madison, WI, May 25, 2017.
  51. Ricke WA, Macoska JA, James TJ, Wynder JL, Liu TT (2017). “The Role of Estrogen Receptor Activation in Benign Prostatic Hyperplasia.” Society for Basic Urologic Research (SBUR), Boston, MA, May 2017.
  52. Wegner KA, Keil KP, Wang Z, Wang P, Bjorling DE, Vezina CM (2017). “Genetic Background Influences Susceptibility of Male Mice to Hormone-induced Urinary Dysfunction.” Abstract for poster presentation, University of Wisconsin Molecular & Environmental Toxicology Spring Symposium, Madison, WI, May 2017.
  53. Ruetten H, Vezina C (2017). “Prostatic Areas of Disease Show Changes in Collagen Fiber Thickness, Diameter, Density, and Orientation.” Abstract for poster presentation, 5th Annual University of Wisconsin-Madison School of Veterinary Medicine-Phi Zeta Research Day, Madison, WI, April 2017.
  54. Patalano-Salsman S, Rodrigeuz-Nieves JA, Almanza D, Avery A, Riley T, Macoska J (2017). “CXCL12-CXCR4 Axis Activation Promotes COP II Vesicle-Mediated Secretion of Collagen by Prostate Myofibroblasts.” Injury, Inflammation and Fibrosis Keystone Symposium, Snowbird, UT, March 26-30, 2017.
  55. Patalano-Salsman S, Rodriguez-Nieves JA, Almanza D, Avery A, Judell-Halfpenney A, Riley T, Macoska J (2016). “CXCL12-CXCR4 Axis Activation Promotes Cop Ii Vesicle-Mediated Secretion Of Collagen By Prostate Myofibroblasts.” Society for Basic Urologic Research (SBUR) Annual Meeting, Nov 10-13, 2016, Scottsdale, AZ.
  56. Ricke WA, McSweeney S, Vellky J (2016). “Expression of Housekeeping Genes across Prostate Cancer Progression.” Society for Basic Urologic Research (SBUR) Annual Meeting, Nov 10-13, 2016, Scottsdale, AZ.
  57. Oakes SR, Wegner KA, Eliceiri K, Vezina CM (2016). “High Thoroughput Computer-Based Analysis of Void Spot Assay Data.” Abstract for poster presentation, Society for Basic Urologic Research (SBUR) Annual Meeting, Nov 10-13, 2016, Scottsdale, AZ.
  58. Wegner KA, Keil KP, Wang Z, Wang P, Bjorling DE, Vezina CM (2016). “Genetic Background Influences Susceptibility of Male Mice to Hormone-induced Urinary Dysfunction.” Abstract for poster presentation, Society for Basic Urologic Research (SBUR) Annual Meeting, Nov 10-13, 2016, Scottsdale, AZ.
  59. Trevena RL, Sullivan R, Wegner KA, Esquibel CR, Eliceiri K, Vezina CM (2016). “Deep Prostate Tissue Immunohistochemical Staining and Fluorescent Confocal Scanning for 3-Dimensional Microenvironment Analysis.” Abstract for poster presentation, Society for Basic Urologic Research (SBUR) Annual Meeting, Nov 10-13, 2016, Scottsdale, AZ.
  60. Ricke WA, Vezina CM, Peterson RE, Moore RW, Ricke EA (2016). “In Utero and Lactational TCDD Exposure Increases Prostatic Estrogen Receptor Alpha and Secondary Complications Associated with Bladder Outlet Obstruction in Mice.” 36thInternational Symposium on Halogenated Persistent Organic Pollutants, Florence, Italy, August-September 2016.
  61. Nicholson TM, Wynder JL, Ricke WA (2016). “The Environmental Estrogen Bisphenol-A is Implicated in Hormonal Induction of Benign Prostatic Hyperplasia in Adult Male Mice.” Urology Research Day, University of Washington, Seattle, WA, June 2016.
  62. Ricke WA, Jeffery J, McLean D, Cunningham K (2016). “In Vivo Modeling of Metastasis Using a Prostate Cancer Progression Cell Line.” Midwestern Preclinical Imaging Consortium, Madison, WI, May 2016.
  63. Ricke WA, Jeffery J, McLean D, Cunningham K (2016). “In Vivo Modeling of Metastasis Using a Prostate Cancer Progression Cell Line.” Society for Basic Urological Research (SBUR), San Diego, CA, May 2016.
  64. Ricke WA, Jeffery J, McLean D, Cunningham K (2016). “In Vivo Modeling of Metastasis Using a Prostate Cancer Progression Cell Line.” Society for Basic Urological Research (SBUR), San Diego, CA, May 2016.
  65. Vom Saal FS, Taylor J, Stahlhut R, Timms BG, Uchtmann KS, Ricke WA (2016). “Fetal Bisphenol A Exposure Alters Body Weight and Male Urogenital Tract Morphology At Birth: Findings from the NIEHS/FDA CLARITY-BPA Research Program.” University of Wisconsin-Madison/UMASS Boston George M.O’Brien Center Symposium: The Environmental Impact on Urologic Health and Disease, Madison, WI, April 2016.
  66. Trevena R, Sullivan R, Wegner KA, Vezina CM, Vokoun C, Eliceiri K, Joseph DB (2016). “Optimization of Whole-Tissue Immunohistochemical Staining and Fluorescence Confocal Scanning for 3-D Prostatic Microenvironmental Analysis.” University of Wisconsin-Madison/UMASS Boston George M.O’Brien Center Symposium: The Environmental Impact on Urologic Health and Disease, Madison, WI, April 2016.
  67. Jeong CH, Vezina CM, Ricke WA (2016). “Alterations of DNA Methyltransferase in BPH-1 Derived Prostate Cancer Progression Model Cell Lines.” University of Wisconsin-Madison/UMASS Boston George M.O’Brien Center Symposium: The Environmental Impact on Urologic Health and Disease, Madison, WI, April 2016.
  68. Lamarre NS, Wynder J, Uchtmann K, Liu T, Wang Z, Vezina CM, Ricke WA, Bjorling DE (2016). “The Effects of Bisphenol A on Urinary Bladder Function.” University of Wisconsin-Madison/UMASS Boston George M.O’Brien Center Symposium: The Environmental Impact on Urologic Health and Disease, Madison, WI, April 2016.
  69. Thomas S, Hao L, Greer T, Vezina CM, Bajpal S, Ashok A, Bieberich CJ, Ricke WA, Li L (2016). “The Urine Proteomes of Genetically-Induced Lower Urinary Tract Dysfunction (LUTD) in Mice.” University of Wisconsin-Madison/UMASS Boston George M.O’Brien Center Symposium: The Environmental Impact on Urologic Health and Disease, Madison, WI, April 2016.
  70. Trevena R, Sullivan R, Wegner KA, Vezina CM, Esquibel CR, Eliceiri K, Joseph DB (2016). “Optimization of Whole-Tissue Immunohistochemical Staining and Fluorescent Confocal Scanning for 3-D Prostatic Microenvironmental Analyses.” Abstract for poster presentation, University of Wisconsin-Madison/UMASS Boston George M.O’Brien Center Symposium: The Environmental Impact on Urologic Health and Disease, Madison, WI, April 2016.
  71. Oakes SR, Eliceiri K, Abler LL, Wegner KA, Vezina CM (2016). “Computer-Based High-Throughput Urinary Function Analysis.” Abstract for poster presentation, University of Wisconsin-Madison/UMASS Boston George M.O’Brien Center Symposium: The Environmental Impact on Urologic Health and Disease, Madison, WI, April 2016.
  72. Joseph DB, Keil KP, Abler LL, Vezina CM (2016). “A Map of DNA Methyltransferase Enzyme Expression in the Mouse Prostate During its Development and in Response to Prostate Injury.” University of Wisconsin-Madison/UMASS Boston George M.O’Brien Center Symposium: The Environmental Impact on Urologic Health and Disease, Madison, WI, April 2016.
  73. Cadena M, Wegner KA, Bushman W, Ricke WA, Vezina CM (2016). “Elucidating Patterns of Smooth Muscle Contractility in Prostatic Urethral Tissue.: University of Wisconsin-Madison/UMASS Boston George M.O’Brien Center Symposium: The Environmental Impact on Urologic Health and Disease, Madison, WI, April 2016.
  74. Oakes SR, Eliceiri K, Abler LL, Wagner KA, Vezina CM (2016). “Computer-Based High-Throughput Urinary Function Analysis.” University of Wisconsin-Madison/UMASS Boston George M.O’Brien Center Symposium: The Environmental Impact on Urologic Health and Disease, Madison, WI, April 2016.
  75. Wynder J, Nicholson T, Lamarre N, Waldman A, vom Saal F, Vezina CM, Bjorling DE, Ricke WA (2017). “The Environmental Estrogen Bishpenol-A Induces Lower Urinary Tract Dysfunction in Adult Male Mice”, Society of Toxicology National Meeting, Baltimore, MD, March 13, 2016.
  76. Macoska J (2016). “Urinary Obstruction and Fibrosis”, Plenary Talk. Society for Urodynamics and Female Urology (SUFU) Annual Meeting, New Orleans, LA, February 23-27, 2016.
  77. Oakes SR, Eliceiri K, Abler LL, Wagner KA, Vezina CM (2016). “Computer-Based High-Throughput Urinary Function Analysis.” University of Wisconsin-Madison Undergraduate Research Symposium, Madison, WI April 2016.
  78. Joseph DB, Keil KP, Abler LL, Vezina CM (2016). “A Map of DNA Methyltransferase Enzyme Expression in the Mouse Prostate During its Development and in Response to Prostate Injury.” WARF Discovery Challenge Symposium, Madison, WI April 2016.
  79. Wynder J, Nicholson T, Lamarre N, Waldman A, vom Saal F, Vezina CM, Bjorling DE, Ricke WA (2016). “The Environmental Estrogen, Bisphenol-A Induces Lower Urinary Tract Dysfunction in Adult Male Mice.” Society of Toxicology National Meeting, Baltimore, MD, March 2016.
  80. Ricke WA, Vellky J (2015). “BOP1 Expression and Localization in Benign Prostatic Disease and Prostate Cancer Progression.” Society for Basic Urologic Research (SBUR), Ft. Lauderdale, FL, November 12-15, 2015.
  81. Lingjun L, Ricke WA, Bieberich C, Ashok A, Bajpai S, Vezina C, Greer T, Hao L, Thomas S (2015). “The Urine Proteomics of Genetically-Induced Lower Urinary Tract Dysfunction (LUTD) in Mice.” Society for Basic Urologic Research (SBUR), Ft. Lauderdale, FL, November 12-15, 2015.
  82. Gharaee-Kermani M, Moore BB, Macoska JA (2015). “Resveratrol-Mediated Repression And Reversion Of Prostatic Myofibroblast Phenoconversion.” Society for Basic Urologic Research (SBUR), Ft. Lauderdale, FL, November 12-15, 2015.
  83. Rodriguez-Nieves, Gharaee-Kermani M, Macoska JA (2015). “CXCL12/CXCR4-Axis Activation Mediates Prostate Myofibroblast Phenoconversion Through Non-Canonical EGFR/MEK/ERK Signaling.” Society for Basic Urologic Research (SBUR), Ft. Lauderdale, FL, November 12-15, 2015.
  84. Wegner KA, Keil KP, Oakes SR, Edokpolor KS, Ricke WA, Vezina CM (2015).  “Characterization of Stroma in Normal Mouse Prostate/Urethra and Mice with Urethral Obstruction.” Abstract for poster presentation, Society for Basic Urologic Research (SBUR), Ft. Lauderdale, FL, November 12-15, 2015.
  85. Wegner K, Vezina CM (2015). “Characterization of Stroma in Normal Mouse Prostate/Urethra and Mice with Urethral Obstruction.” Society for Basic Urologic Research (SBUR), Ft. Lauderdale, FL, November 12-15, 2015.
  86. Jeong CH, Vezina CM, Ricke WA (2015). “Alterations of DNA Methyltransferase in BPH-1 Derived Prostate Cancer Progression Model Cell Lines.” Society for Basic Urologic Research (SBUR), Ft. Lauderdale, FL, November 12-15, 2015.
  87. Bauman TM, Vezina CM, Halberg RB, Huang W, Peterson RE, Ricke WA (2015). “Expression and Co-localization of Beta-Catenin and Lymphoid Enhancing Factor-1 in Prostate Cancer Progression.” Society for Basic Urologic Research (SBUR), Ft. Lauderdale, FL, November 12-15, 2015.
  88. Wynder J, Nicholson T, Wood R, Ricke WA (2015). “Testosterone and Bisphenol A Exposure Induces Increased Prostate and Bladder Mass of Male Mice.” University of Wisconsin-Madison Molecular and Environmental Toxicology Center Annual Retreat, Madison, WI, June 17, 2015.
  89. Ricke WA, Vellky J, McLean D (2015). “Fibroblast growth factor 5 increases expression through prostate cancer progression.” Society for Basic Urologic Research (SBUR), New Orleans, LA, May 2015.
  90. Ricke WA, Vellky J, McLean D (2015). “Fibroblast Growth Factor 5 Increases Expression Through Prostate Cancer Progression.” Society for Basic Urologic Research (SBUR), New Orleans, LA, May 2015.
  91. Bauman TM, Ricke EA, Huang W, Ricke WA (2015). “A Tissue Specific Role for Ligand Independent Arv7 Signaling in Benign Prostate Pathogenesis.” American Urological Association (AUA), New Orleans, LA, May 2015.
  92. Nicholson TM, Wynder J, Ricke WA (2015). “Bladder Fibrosis in Male Mice Treated with Testosterone and Estradiol is Not Prevented by the Selective Estrogen Receptor Modulator Raloxifene.” American Urological Association (AUA), New Orleans, LA, May 2015.
  93. Hao L, Greer T, Zhong X, Page D, Lee S, Vezina CM, Ricke WA, Parker PC, Bjorling DE, Bushman W, Li L (2015). “Combining DiLeu Isobaric Labeling and Label-free Approaches for Metabolite Quantification and Biomarker Discovery of Lower Urinary Tract Symptoms (LUTS).” 63rdAnnual ASMS Conference on Mass Spectrometry and Allied Topics, St. Louis, MO, May 2015.
  94. Hao L, Greer T, Vezina CM, Ricke WA, Marker PC, Bjorling DE, Bushman W, Li L (2015). “Identification of Potential Metabolite Biomarkers of Lower Urinary Tract Symptoms (LUTS) in Mouse and Human Urine.” University of Wisconsin-Madison/UMASS Boston Spring Symposium: Role of Fibrosis in Signaling and Lower Urinary Tract Disease, Madison, WI, April 2015.
  95. Wynder J, Nicholson T, Wood R, Ricke WA (2015). “Testosterone and Bisphenol A Exposure Induces Increased Prostate and Bladder Mass of Male Mice”, University of Wisconsin-Madison/UMASS Boston Spring Symposium: Role of Fibrosis in Signaling and Lower Urinary Tract Disease, Madison, WI, April 2015.
  96. Ricke WA, Lee C, Clapper T, Schneider A, Moore RW, Keil KP, Abler LL, Wynder J, López Alvarado A, Beaubrun I, Vo J, Peterson RE, Vezina CM (2015). “Fetal TCDD Exposure Increases Adult Male Mouse susceptibility to Urinary Dysfunction.” The 54thAnnual Meeting of the Society of Toxicology, San Diego, CA, March 2015.
  97. Nicholson TM, Bauman T, Ricke WA (2014). “Bladder Fibrosis in Male Mice Treated with Testosterone and Estradiol is Not Prevented by the Selective Estrogen Receptor Modulator Raloxifene.” Society for Basic Urologyic Research (SBUR), Dallas, TX, November 2014.
  98. Gamat M, Parkhurst L, Steinke L, Marker PC (2014). “Ornithine Decarboxylase Activity is Required for Prostatic Bud Initiation.” 6thGreat Lakes Nuclear Receptor Conference (GLNRC), Madison, WI, October 17-18, 2014.

SCIENTIFIC PRESENTATIONS/OUTREACH

  1. 2019 May, American Urological Association and Society for Basic Urologic Research Basic Sciences Symposium: “Cell Types of Development, Homeostasis, and Disease in the Urogenital Tract”, Chicago, IL, May 2019. “Social (and Antisocial) Cell Signaling Networks in the Urinary Tract”, Dr. Chad Vezina.
  2. 2018 December, Collaborating for the Advancement of Interdisciplinary Research in Benign Urology (CAIRIBU) Conference, Ellicott City, Maryland, December 2018.  “MRI Shows Bladder Wall Thickness and Detrusor Muscle Volume Increase in Association with Age-dependent Increase in Prostate Volume”, Dr. Alejandro Roldán-Alzate.
  3. 2018 December, Collaborating for the Advancement of Interdisciplinary Research in Benign Urology (CAIRIBU) Conference, Ellicott City, Maryland, December 2018.  “Exogenous Hormone Exposure: A Potential Platform for Testing Interventional Therapies for Lower Urinary Tract Dysfunction in Male Mice”, Chelsea A. O’Driscoll.
  4. 2018 December, Collaborating for the Advancement of Interdisciplinary Research in Benign Urology (CAIRIBU) Conference, Ellicott City, Maryland, December 2018.  “FGF5 Regulation of Androgen Receptor in Prostate Cells”, Dalton McLean.
  5. 2018 December, Collaborating for the Advancement of Interdisciplinary Research in Benign Urology (CAIRIBU) Conference, Ellicott City, Maryland, December 2018.  “Building a Comprehensive Cellular Anatomy of the Normal and Diseased Human Prostate”, Dr. Douglas W. Strand.
  6. 2018 December, Collaborating for the Advancement of Interdisciplinary Research in Benign Urology (CAIRIBU) Conference, Ellicott City, Maryland, December 2018.  “Impact of Age and Castration on Canine Prostate Collagen Organization”, Hannah Ruetten.
  7. 2018 December, Collaborating for the Advancement of Interdisciplinary Research in Benign Urology (CAIRIBU) Conference, Ellicott City, Maryland, December 2018.  “Does Size Matter? Reduced Prostate Size Alters Urinary Function in Male Mice.”, Helen Zhang.
  8. 2018 December, Collaborating for the Advancement of Interdisciplinary Research in Benign Urology (CAIRIBU) Conference, Ellicott City, Maryland, December 2018.  “Isolating Prostate Stem-like Cells in a Progressive Cell Line Model”, Katelin Cunningham.
  9. 2018 December, Collaborating for the Advancement of Interdisciplinary Research in Benign Urology (CAIRIBU) Conference, Ellicott City, Maryland, December 2018.  “Developmental Exposure to Polychlorinated Biphenyls (PCBs) Induces Bladder Inflammation, Increased Nerve Density, and Voiding Dysfunction in Young Adult Mice.”, Dr. Kimberly P. Keil.
  10. 2018 December, Collaborating for the Advancement of Interdisciplinary Research in Benign Urology (CAIRIBU) Conference, Ellicott City, Maryland, December 2018.  “Characterization of Srd5a2creErt2Expression in the Mouse Prostate: A Potential Source of Stromal Progenitors”, Kyle A. Wegner.
  11. 2018 December, Collaborating for the Advancement of Interdisciplinary Research in Benign Urology (CAIRIBU) Conference, Ellicott City, Maryland, December 2018.  “Connecting Development and Disease: Presenting A Potential Mouse Model for BPH”, Melissa Gamat.
  12. 2018 December, Collaborating for the Advancement of Interdisciplinary Research in Benign Urology (CAIRIBU) Conference, Ellicott City, Maryland, December 2018.  “New Techniques to Measure Coordinated Ca2+Signals, Micromotions, and Transient Pressure Events in the Mouse Urinary Bladder”, Dr. Nathan R. Tykocki (University of Vermont).
  13. 2018 December, Collaborating for the Advancement of Interdisciplinary Research in Benign Urology (CAIRIBU) Conference, Ellicott City, Maryland, December 2018.  “The Urine Proteomics of Genetically-induced Lower Urinary Tract Dysfunction (LUTD) Mice”, Sam Thomas.
  14. 2018 December, Collaborating for the Advancement of Interdisciplinary Research in Benign Urology (CAIRIBU) Conference, Ellicott City, Maryland, December 2018.  “Monitoring Serium Steroids in a Hormone-Induced Model of Lower Urinary Tract Dysfunction”, Sam Thomas.
  15. 2018 December, Collaborating for the Advancement of Interdisciplinary Research in Benign Urology (CAIRIBU) Conference, Ellicott City, Maryland, December 2018.  “Using Mouse and DrosophilaModels to Dissect the Role of DDX3-dependent Translational Control in BPH”, Sarah Neuman.
  16. 2018 December, Collaborating for the Advancement of Interdisciplinary Research in Benign Urology (CAIRIBU) Conference, Ellicott City, Maryland, December 2018.  “The Impact of Age on the Lower Urinary Tract of Mice”, Dr. Teresa T. Liu.
  17. 2018 December, Collaborating for the Advancement of Interdisciplinary Research in Benign Urology (CAIRIBU) Conference, Ellicott City, Maryland, December 2018.  “Mind Over Matter – Healthy Bowels, Healthy Bladder: A Randomized Controlled Trial”, Heidi Brown.
  18. 2018 December, Collaborating for the Advancement of Interdisciplinary Research in Benign Urology (CAIRIBU) Conference, Ellicott City, Maryland, December 2018.  “CXCL12 Mediates Increased Prostatic Fibrosis in Mice Fed a High Fat Diet”, Dr. Jill A. Macoska.
  19. 2018 December, Collaborating for the Advancement of Interdisciplinary Research in Benign Urology (CAIRIBU) Conference, Ellicott City, Maryland, December 2018.  “MicroRNA-29a/b1 Inhibits Bladder Fibrosis and Supports Normal Bladder Function”, Dr. Dale E. Bjorling.
  20. 2018 November, Society for Basic Urologic Research (SBUR) Fall Symposium Trainee Workshop, Palm Springs, CA. “Formulating a career development plan to maximize training productivity”, Dr. Chad Vezina.
  21. 2018 August, Jackson Laboratories Workshop on Techniques in Modeling Human Cancer in Mice,Bar Harbor, ME.“Prostate Cancer: Clinical Problems, Research Resources and Opportunities”, Dr. Chad Vezina
  22. 2018 July, UMASS-Boston, “Connecting Cellular Behaviors to Prostatic Disease”, Dr. Chad Vezina.
  23. 2018 July, The Mayo Clinic of Rochester Nephrology Summer Undergraduate Research Program, Rochester, MN, “Benign Prostate Disease: What It Is and Why You Should Care”, Dr. Chad Vezina.
  24. 2018 June, External Expert Panel (EEP) Meeting, Bethesda, MD, “Progress and Future of the UW-Madison & UM-Boston O’Brien Center”, Dr. William Ricke.
  25. 2018 June, External Expert Panel (EEP) Retreat, Bethesda, MD, “Progress and Future of the UW-Madison & UM-Boston O’Brien Center”, Dr. William Ricke.
  26. 2018 June, Urology Research Day, University of Washington, Seattle, WA, June 16, 2018. “Defining Endpoints of Recovery of Urinary Health after Prostatectomy”, Dr. Tristan Nicholson.
  27. 2018 May, University of Wisconsin Undergraduate Research Symposium, Madison, WI. “Understanding the Role of Prostate Fibrosis in Mouse Models of Hormone-Induced Urinary Dysfunction”, Brett Mueller
  28. 2018 March, Society of Toxicology National Meeting, San Antonio, TX, March 13, 2018. “Exposure to Bisphenols Causes Lower Urinary Tract Dysfunction in Male Mice through an ER Alpha-Dependent Mechanism”, Dr. Jalissa Wynder (Nguyen) & Dr. Clara Jeong.
  29. 2018 February, University of Puget Sound, Tacoma, WA, Chemistry, “Studying Cell Signaling in Complex Environments Using Open Microfluidics”, Dr. Ashleigh Theberge.
  30. 2018 January, University of Wisconsin Developmental Endocrinology Research Group, Madison, WI. “Novel Endpoints and Mouse Strains in Prostate Research”, Dr. Kyle Wegner.
  31. 2018 January, University of Wisconsin Molecular and Environmental Toxicology Center Seminar Series,Madison, WI. “Urinary Complications of Benign Prostatic Disease: Impact of Fetal and Neonatal Environment”, Dr. Kyle Wegner.
  32. 2017 November, Veterinary Histology, School of Veterinary Medicine, University of Wisconsin-Madison, Madison WI. “Prostate Histology Research Correlate”, Hannah Ruetten.
  33. 2017 November, Society of Toxicology Midwest Regional Chapter Annual Meeting,Chicago, IL. “Urinary Complications of Benign Prostatic Disease: Impact of Fetal and Neonatal Environment”, Dr. Kyle Wegner.
  34. 2017 November, University of Wisconsin-Madison Molecular and Environmental Toxicology Center, Madison, WI, November 2, 2017. “Investigating the Role of Environmental Estrogens in Lower Urinary Tract Dysfunction”, Dr. Jalissa Wynder (Nguyen).
  35. 2017 October, Southern University’s 6thAnnual Clarke Symposium, Baton Rouge, LA, October 5, 2017. “My Journey Towards a Career in Toxicology”, Dr. Jalissa Wynder (Nguyen).
  36. 2017 October, University of Wisconsin Developmental Endocrinology Research Group, Madison, WI. “Collagen Architecture of the Prostate: Impact of Age and Androgen Status”, Hannah Ruetten.
  37. 2017 October, University of Wisconsin Developmental Endocrinology Research Group, Madison, WI. “A Nightmare in the Prostate”, Dr. Kyle Wegner.
  38. 2017 September, Santa Clara University, Santa Clara, CA, Chemistry, “Studying Cell Signaling in Complex Environments Using Open Microfluidics”, Dr. Ashleigh Theberge.
  39. 2017 August, O’Brien Center Retreat, Mount Morris, WI, August 2017. “Progress and Future of the UW-Madison & UM-Boston O’Brien Center”, Dr. William Ricke.
  40. 2017 July, University of Wisconsin & University of Massachusetts-Boston O’Brien Research Center Summer Program for Undergraduates in Urologic Research, Madison, WI. “Toxicology: Overview and Career Options/Imaging Demonstration”, Dr. Kyle Wegner.
  41. 2017 June, External Expert Panel (EEP) Meeting, Bethesda, MD, “Progress and Future of the UW-Madison & UM-Boston O’Brien Center”, Dr. William Ricke.
  42. 2017 June, External Expert Panel (EEP) Retreat, Bethesda, MD, “Progress and Future of the UW-Madison & UM-Boston O’Brien Center”, Dr. William Ricke.
  43. 2017 June, Northwest Regional Meeting – American Chemical SocietyBiochemistry Session, Corvallis, OR, “Microscale Culture Systems to Probe Small Molecule Signaling”, Dr. Ashleigh Theberge.
  44. 2017 June, Northwest Regional Meeting – American Chemical Society Analytical Chemistry Session, Corvallis, OR, “Open Microfluidics for Chemical Analysis of Organotypic Cell Cultures”, Dr. Ashleigh Theberge.
  45. 2017 May, University of Wisconsin Developmental Endocrinology Research Group, Madison, WI. “One Health Approach to Studying Benign Prostatic Hyperplasia”, Hannah Ruetten.
  46. 2017 May, University of Wisconsin-Madison Summer Program for Undergraduate Urology Research (SPUUR), Madison, WI, May 25, 2017. “How to Get the Most Out of a Summer Internship”, Dr. Jalissa Wynder (Nguyen).
  47. 2017 May, University of Wisconsin Molecular and Environmental Toxicology Center Seminar Series,Madison, WI. “Unraveling the Prostate Collagen Network”, Dr. Kyle Wegner.
  48. 2017 May, University of Washington, Bioengineering, Seattle, WA, “Studying Cell Signaling in Complex Environments Using Open Microfluidics”, Dr. Ashleigh Theberge.
  49. 2017 April, University of Wisconsin Developmental Endocrinology Research Group, Madison, WI. “Objective Collagen Detection in Thin Sections”, Dr. Kyle Wegner.
  50. 2017 March, University of Wisconsin Laboratory for Optical and Computational Instrumentation Seminar Series, Madison, WI. “Mesoscale Imaging of Stromal Elements and Interactions in Histologic Preparations”, Dr. Kyle Wegner.
  51. 2017 March, University of California, Berkeley, Bioengineering, Berkeley, CA, “Studying Cell Signaling in Complex Environments Using Open Microfluidics”, Dr. Ashleigh Theberge.
  52. 2017 February, University of Wisconsin Developmental Endocrinology Research Group, Madison, WI. “Prostatic Collagen Architecture in Neutered and Intact Canines”, Hannah Ruetten.
  53. 2017 January, Resident Seminar, Department of Urology, University of Washington, Seattle, WA, January 25, 2017. “Estrogen Receptor-alpha is a Key Mediator and Therapeutic Target in Benign Prostatic Hyperplasia”, Dr. Tristan Nicholson.
  54. 2017 January, University of Toronto, Mechanical and Industrial Engineering, Toronto, Canada, “Studying Cell Signaling in Complex Environments Using Open Microfluidics”, Dr. Ashleigh Theberge.
  55. 2016 December, EMBS Micro and Nanotechnology in Medicine (IEEE Conference), Waikoloa, HI, “Examining Cellular Signaling in Complex Environments with Microscale Systems”, Dr. Ashleigh Theberge.
  56. 2016 November, Society for Basic Urologic Research Annual Meeting, Scottsdale, AR, “Examining Cell Signaling in Complex Environments with Microscale Systems”, Dr. Ashleigh Theberge.
  57. 2016 October, University of Wisconsin Carbone Cancer Center Translational Imaging Group, Madison, WI. “Mesoscale Imaging of Stromal Elements and Interactions in Histologic Preparations”, Dr. Kyle Wegner.
  58. 2016 September, University of Wisconsin Developmental Endocrinology Research Group, Madison, WI. “Genetic Background Influences Susceptibility of Male Mice to Hormone-Induced Urinary Dysfunction”, Dr. Kyle Wegner.
  59. 2016 September, University of Wisconsin-Department of Urology Grand Rounds, Madison, WI, September 2016. “Modeling Prostate Disease in Mice and Cell Culture.”
  60. 2016 August, O’Brien Center Retreat, Mount Morris, WI, August 2016. “Progress and Future of the UW-Madison & UM-Boston O’Brien Center”, Dr. William Ricke.
  61. 2016 August, University of Wisconsin Comparative Biomedical Sciences Departmental Meeting, Minoqua, WI. “The Role of Prostate Fibrosis in Male Urinary Dysfunction”, Dr. Kyle Wegner.
  62. 2016 July, University of Wisconsin Developmental Endocrinology Research Group, Madison, WI. “New Findings in Prostate Fibrosis”, Dr. Kyle Wegner.
  63. 2016 July, Pacific Northwest National Laboratory, Richland, WA, “Studying Cell Signaling in Complex Environments Using Open Microfluidics”, Dr. Ashleigh Theberge.
  64. 2016 June, University of Wisconsin-Madison Endocrinology and Reproductive Physiology Annual Symposium, Madison, WI. “Unraveling the Connection Between Prostate and Urinary Dysfunction”, Dr. Chad Vezina.
  65. 2016 June, External Expert Panel (EEP) Meeting, Bethesda, MD, “Progress and Future of the UW-Madison & UM-Boston O’Brien Center”, Dr. William Ricke.
  66. 2016 June, External Expert Panel (EEP) Retreat, Bethesda, MD, “Progress and Future of the UW-Madison & UM-Boston O’Brien Center”, Dr. William Ricke.
  67. 2016 May, American Urologic Association, Plenary Session, San Diego, CA, May 8, 2016. “Patient Stratification in the Treatment of BPH”, Dr. William Ricke.
  68. 2016 April, Duke University, Multidisciplinary Benign Urology Research Day, KURe and PMRC, Durham, NC, April 29, 2016. “Hormonal Regulation and Fibrosis in the Lower Urinary Tract”, Dr. William Ricke.
  69. 2016 April, University of Wisconsin/UMASS Boston George M. O’Brien Center Symposium on Environmental Impact on Urologic Health and Disease, Madison, WI. “Estrogen Induction of LUTD in Mice”, Dr. William Ricke.
  70. 2016 April, University of Wisconsin/UMASS Boston George M. O’Brien Center Symposium on Environmental Impact on Urologic Health and Disease,Madison, WI. “Impact of AHR Signaling on Benign Urinary Function”, Dr. Chad Vezina.
  71. 2016 April, University of Wisconsin/UMASS Boston George M. O’Brien Center Symposium on Environmental Impact on Urologic Health and Disease, Madison, WI.  “Picrosirius Red: A Versatile Tool for Analyzing Collagen in the Lower Urinary Tract”, Dr. Kyle Wegner.
  72. 2016 March (Stephen ‘Royal’ Oakes), University of Wisconsin & University of Massachusetts-Boston O’Brien Research Center Seminar Series, Madison WI. “Computer-Based High-Throughput Urinary Function Analysis”, Stephen ‘Royal’ Oakes.
  73. 2016 March, University of Wisconsin & University of Massachusetts-Boston O’Brien Research Center Seminar Series, Madison WI. “Large Sample Tissu eArrays and Picrosirius Red: Useful Tools for Prostate Histological Analysis”, Dr. Kyle Wegner.
  74. 2016 March, Pittcon, Symposium: Quantifying the Tumor Microenvironment, Atlanta, GA, “Examining Cellular Signaling in Complex Environments with Microscale Systems”, Dr. Ashleigh Theberge.
  75. 2016 February, The Society for Urodynamics and Female Urology (SUFU) Annual Meeting, New Orleans, LA, February 23-27, 2016. “Urinary Obstruction and Fibrosis”, Dr. Jill Macoska.
  76. 2016 February, University of Wisconsin Molecular and Environmental Toxicology Center Seminar Series,Madison, WI. “Developmental Origins of Adult Disease: Effects of Fetal Dioxin Exposure on Adult Prostate Disease Progression”, Dr. Kyle Wegner.
  77. 2016 January, Fred Hutchinson Cancer Research Center, Program in Prostate Cancer Research (PPCR), Seattle, WA, “Studying Cell Signaling in Complex Environments Using Open Microfluidics”, Dr. Ashleigh Theberge.
  78. 2015 December, University of Massachusetts Boston, Boston, MA, December 7, 2015. “Identifying Molecular Mechanisms of Prostate Cancer Using Transposon-Mediated Mutagenesis and Mouse Models”, Dr. Paul Marker.
  79. 2015 December, University of Wisconsin Developmental Endocrinology Research Group, Madison, WI. “The Role of Beta Catenin in Benign Prostatic Disease”, Dr. Kyle Wegner.
  80. 2015 December, University of Wisconsin Prostate Researchers Group, Madison, WI. “The Role of Beta Catenin in Benign Prostatic Disease”, Dr. Kyle Wegner.
  81. 2015 November, National Institute of Environmental Health Sciences, Consortium Linking Academic and Regulatory Insights on BPAToxicity (CLARITY-BPA), Durham, NC, November 2015.  “Estrogenic Effects of BPA on the Lower Urinary Tract of Postnatal Day 1 Rats”, Dr. William Ricke.
  82. 2015 November, Society for Basic Urologic Research (SBUR) Fall Symposium, Ft. Lauderdale, FL. “Inflammation of the Lower Urinary Tract”, Dr. Dale Bjorling.
  83. 2015 November, Society for Basic Urologic Research (SBUR) Fall Symposium, Ft. Lauderdale, FL. “The Influence of Intermittent Hypoxia and Diabetes on Lower Urinary Tract Function”, Dr. Chad Vezina.
  84. 2015 November, Columbia University: Symposium on The Genetic Origins and Complications of Urinary Tract Abnormalities, New York, NY. “A Role for DNA Methylation in Prostate Development and Urinary Function”, Dr. Chad Vezina.
  85. 2015 October, University of Illinois Chicago Medical School (Rockford satellite), Rockford, IL, October 7, 2015. “Identifying molecular mechanisms of prostate cancer and BPH using mouse models”, Dr. Paul Marker.
  86. 2015 September, Urology Program Directors Meeting, Wisconsin K12cure Program, Madison, WI, September 2015. “University of Wisconsin K12cure Training Program”, Dr. Dale Bjorling.
  87. 2015 September, NIH/NIDDK Urology Developmental Centers Meeting, Madison, WI. “Estrogen Action in Urinary Dysfunction”, Dr. William Ricke.
  88. 2015 September, NIH/NIDDK Urology Developmental Centers Meeting, Madison, WI. “Roles of Beta-Catenin in Urinary Dysfunction”, Dr. Chad Vezina.
  89. 2015 September, NIDDK Urology Developmental Centers Meeting, Madison, WI, “Probing Paracrine Signaling in Benign Prostatic Hyperplasia with New Microfluidic Methods”, Dr. Ashleigh Theberge.
  90. 2015 August, O’Brien Center Retreat, Mount Morris, WI, August 2015. “Progress and Future of the UW-Madison & UM-Boston O’Brien Center”, Dr. William Ricke.
  91. 2015 June, NIH/NIDDK Urology Centers Steering Committee Meeting, Bethesda, MD, June 2015. “Overview of O’Brien Center”, Dr. William Ricke.
  92. 2015 June, External Expert Panel (EEP) Meeting, Bethesda, MD, “Progress and Future of the UW-Madison & UM-Boston O’Brien Center”, Dr. William Ricke.
  93. 2015 June, External Expert Panel (EEP) Retreat, Bethesda, MD, “Progress and Future of the UW-Madison & UM-Boston O’Brien Center”, Dr. William Ricke.
  94. 2015 June, Gordon Research Conference on the Physics and Chemistry of Microfluidics, West Dover, VT, “Metabolomics at the Microscale”, Dr. Ashleigh Theberge.
  95. 2015 May, American Urological Association Basic Science Symposium, New Orleans, LA, May 15 2015. “Estrogen Regulation in the Prostate”, Dr. William Ricke.
  96. 2015 May, American Urological Association, New Orleans, LA, May 15 2015. “Estrogen Regulation in BPH and the Lower Urinary Tract”, Dr. William Ricke.
  97. 2015 May, University of Wisconsin Developmental Endocrinology Research Group, Madison, WI. “The Role of Prostate Fibrosis in Lower Urinary Dysfunction”, Dr. Kyle Wegner.
  98. 2015 April, University of Wisconsin/UMASS Boston George M. O’Brien Urology Research Symposium, Madison,WI, April 8-9, 2015. “Prostatic Fibrosis as a Mediator of Prostate Disease”, Dr. William Ricke.
  99. 2015 April, University of Wisconsin/UMASS Boston George M. O’Brien Urology Research Symposium, Madison,WI, April 8-9, 2015. “Role of Fibrosis in Signaling and Lower Urinary Tract Disease”, Dr. Jill Macoska.
  100. 2015 February, Clark-Atlanta University, Atlanta, GA, February 6, 2015. “Hormone Action and Paracrine Interactions in Prostate Carcinogenesis”, Dr. William Ricke.
  101. 2015 February, University of Wisconsin Developmental Endocrinology Research Group, Madison, WI. “A New Direction: Prostate Fibrosis”, Dr. Kyle Wegner.
  102. 2015 February, University of Chicago, Chicago IL. “Mapping the Developing Mouse Prostate to Reveal New Ductal Growth Mechanisms: A Focus on DNA Methylation”, Dr. Chad Vezina.
  103. 2015 February, Pathology Student Seminar, University of Rochester, Rochestern, NY, February 3, 2015. “Estrogen Receptor-alpha is a Key Mediator and Therapeutic Target in Benign Prostatic Hyperplasia”, Dr. Tristan Nicholson.
  104. 2015 February, University of North Carolina, Chapel Hill, Department of Biomedical Engineering, Chapel Hill, NC, “Studying Cell Signaling in Complex Environments Using Open Microfluidics”, Dr. Ashleigh Theberge.
  105. 2015 February, University of California, Davis, Department of Chemistry, Davis, CA, “Studying Cell Signaling in Complex Environments Using Open Microfluidics”, Dr. Ashleigh Theberge.
  106. 2015 January, University of Wisconsin-Madison Prostate Cancer Research Group Meeting, Madison, WI, January 9, 2015. “Estrogen Receptors in Benign Prostatic Hyperplasia”, Dr. Tristan Nicholson.
  107. 2015 January, University of Utah, Department of Biochemistry, Salt Lake City, UT, “Studying Cell Signaling in Complex Environments Using Open Microfluidics”, Dr. Ashleigh Theberge.
  108. 2015 January, Indiana University, Department of Chemistry, Bloomington, IN, “Studying Cell Signaling in Complex Environments Using Open Microfluidics”, Dr. Ashleigh Theberget.
  109. 2015 January, University of Washington, Department of Chemistry, Seattle, WA, “Studying Cell Signaling in Complex Environments Using Open Microfluidics”, Dr. Ashleigh Theberge.
  110. 2014 December, University of Wisconsin-Madison Vertebrate Development Biology Group Presentation, Madison, WI, December 16, 2014. “Environmental Estrogens and BPH”, Dr. Jalissa Wynder (Nguyen).
  111. 2014 December, NIH/NIDDK Urology Developmental Centers Meeting, Pacific Grove, CA. “Urinary Biomarkers of Lower Urinary Tract Symptoms (LUTS) in Men”, Dr. Paul Marker.
  112. 2014 December, NIDDK Urology Developmental Centers Meeting, Asilomar, CA, “Examining Microenvironmental Regulation of Angiogenesis in Benign Prostatic Hyperplasia with Microscale Culture”, Dr. Ashleigh Theberge
  113. 2014 December, NIH/NIDDK Urology Developmental Centers Meeting, Pacific Grove, CA. “Developmental Mapping of the Prostate”, Dr. Chad Vezina.
  114. 2014 December, University of Wisconsin-Madison, Department of Biomedical Engineering, Madison, WI, “Studying Cell Signaling in Complex Environments Using Open Microfluidics”, Dr. Ashleigh Theberge.
  115. 2014 November, Society for Basic Urologic Research (SBUR) Fall Meeting, Dallas, TX, November 13-16, 2014. “Estrogen Regulation of Fibrosis in Lower Urinary Tract Dysfunction”, Dr. William Ricke.
  116. 2014 November, School of Veterinary Medicine, University of Wisconsin-Madison, WI, “Prostate Research in the Vezina Lab:  Past, Present, and Future”, Dr. Chad Vezina.
  117. 2014 November, Society for Basic Urologic Research Fall Symposium, Dallas, TX, “Microscale Metabolomics Platform for Studying Cell Signaling in Benign Prostatic Hyperplasia”, Dr. Ashleigh Theberge.
  118. 2014 October, University of Wisconsin Department of Urology Uehling Lectures, Madison, WI, October 24, 2014. “Hormones and BPH: Glandular Growth and/or Fibrosis”, Dr. William Ricke.
  119. 2014 October, Association of Underrepresented Minority Fellows Symposium (AUMF), Cleveland, OH, October 18, 2014. “Testosterone and Bisphenol A Exposure Induces Increased Prostate Mass of Male Mice”, Dr. Jalissa Wynder (Nguyen).
  120. 2014 October, University of Wisconsin-Madison Molecular and Environmental Toxicology Center Annual Retreat, Madison, WI, October 16, 2014. “Bisphenol A Exposure and Prostate Disease”, Dr. William Ricke, Dr. Tristan Nicholson, & Dr. Jalissa Wynder (Nguyen).
  121. 2014 May, Vanderbilt Center for Benign Urologic Diseases, Nashville, TN. “Emerging Players in Urinary Dysfunction: Epigenetics and Sleep Apnea”, Dr. Chad Vezina.

HOSTED SYMPOSIA & SEMINARS

  1. June 26, 2019: Michael Freeman, PhD, Cedars-Sinai Medical Center
  2. May 22, 2019: Aria Olumi, MD, Beth Israel Deaconess Medical Center and Harvard Medical School, “Epigenetic Changes in 5-Alpha Reductase 2 – Opportunities for Personalized Care for Management of Prostatic Disease”
  3. CROSS-DISCIPLINE INTERACTION: May 15, 2019: Kristen Malecki, PhD, MPH, UW-Madison Population Health Sciences, “Translating Research for Human Health and the Environment – An Epidemiologist’s Perspective”
  4. May 1, 2019: Adam Klausner, MD, Virginia Commonwealth University, “Urodynamics 2.0: Novel Technologies for the Evaluation of Voiding Dysfunction”
  5. CROSS-DISCIPLINE INTERACTION: April 17, 2019: Melissa Skala, PhD, UW-Madison, Biomolecular Engineering, “Metabolic Imaging of Cellular Heterogeneity in Cancer”
  6. April 12, 2019: Matt Conklin, PhD, UW-Madison, Department of Cell and Regenerative Biology, “Methods for Decoding the Collagen ECM in Prostate Cancer and BPH: Out of Many Fibers, A Biomarker?”
  7. April 12, 2019: Petra Popovics, PhD, Case Western Reserve University, “Osteopontin: A Key Link Between Inflammation and Prostatic Fibrosis”
  8. INTERACTION WITH COLUMBIA O’BRIEN CENTER: April 12, 2019, Nicholas Steers, PhD, Columbia University, “Elucidating the Origin and Function of Bladder Resident Macrophages”
  9. INTERACTION WITH GRADUATE TRAINEE:April 12, 2019, Jordan Vellky, PhD Candidate, “Housekeeping Genes and Rigor & Reproducibility”
  10. April 12, 2019: Scott Gabrielsen, MD, Baylor College of Medicine, “Finding the Needle in the Haystack: Harnessing Big Data to Identify Novel Causes of Male Infertility”
  11. April 12, 2019: Kim Keil, PhD, UW-Madison, School of Veterinary Medicine, Department of Surgical Sciences, “Developmental Exposure to Polychlorinated Biphenyls (PCBs) Induces Bladder Inflammation, Increased Nerve Density and Voiding Dysfunction in Young Adult Mice”
  12. April 12, 2019: Adriane Sinclair, PhD, UCSF, “Hypospadias in Humans and Mice”
  13. April 12, 2019: Sarah Neuman, PhD, UW-Madison, School of Pharmacy, “Translational Control in Steroid Hormone Signaling: Insights from Drosophilia”
  14. April 12, 2019: Dale Bjorling, DVM, UW-Madison, School of Veterinary Medicine, “Rodent Urodynamics: What’s the Point?”
  15. April 11, 2019: Kristina Penniston, PhD, NIH/NIDDK, “Synergistic Interdisciplinary Research Interactions in Benign Urology: How Can We Be More Like Bacteria?”
  16. April 11, 2019: Douglas Strand, PhD, UT-Southwestern, “Ring Around the Urethra: Do SRD5A2+ Fibroblasts Cause LUTS?”
  17. April 11, 2019: Chad Vezina, PhD, UW-Madison, Department of Comparative Biosciences, “To Be or Not to Be: How Does a Prostate Cell Decide to Cause Fibrosis?”
  18. INTERACTION WITH GRADUATE TRAINEE:April 11, 2019: Anne Turco, UW-Madison PhD Candidate, ”The Big Squeeze: The Role of Prostate Smooth Muscle Contraction in Urinary Obstruction”
  19. April 11, 2019: Jill Macoska, PhD, University of Massachusetts-Boston, “From Mice to Men: Activation of the CSCL12/CXCL4 Axis in Prostatic Fibrosis”
  20. INTERACTION WITH U.PITTSBURGH O’BRIEN CENTER: April 11, 2019: Pradeep Tyagi, PhD, University of Pittsburgh, “Insights from the Link Between Adipokine Levels in Urine and the Obesity of BPH Patients”
  21. April 11, 2019: Scott Bauer, MD, UCSF, “Using Large Observational Studies to Study Mechanisms of BPH/LUTS”
  22. April 11, 2019: Balakrishna Lokeshwar, PhD, Augusta University, “The Interleukin-8 Axis in the Development of BPH”
  23. CROSS-DISCIPLINE INTERACTION: April 11, 2019: Diego Hernando, PhD, UW-Madison, Department of Radiology and Medical Physics, “Emerging MRI Techniques: New Tools for Research and the Clinic”
  24. INTERACTION WITH UW-MADISON K12:April 11, 2019, Teresa Liu, PhD, K12 Scholar, UW-Madison, “Estrogen Receptor Expression and Steroid Hormone Metabolism in Benign Prostatic Hyperplasia”
  25. April 11, 2019: Will Ricke, PhD, UW-Madison, Department of Urology, “Are All Men Destined to Get BPH?”
  26. INTERACTION WITH GRADUATE TRAINEE:April 11, 2019, Dalton McLean, PhD Candidate, “MRI-Based Method for Analyzing Lower Urinary Tract Dysfunction in Adult Male Mice”
  27. INTERACTION WITH TRAINEE: April 11, 2019: Brett Mueller, “Exploring Collagen Changes in C57BL/6J Mice with Bacterial-induced Prostate Inflammation”
  28. April 11, 2019: Jeremy Duffield, MD, PhD, FRCP, Vertex Pharmaceuticals, “Cellular and Molecular Mechanisms Underlying Solid Organ Fibrosis: What to Target and Why?”
  29. April 1, 2019: Aaron Mickle, PhD, Washington University School of Medicine, “Optogenetic Neuromodulation of Bladder Pain and Function”
  30. March 28, 2019: Beatrice Knudsen, MD, PhD, Cedars-Sinai Medical Center, “Computational Pathology and the Tumor Microenvironment”
  31. March 20, 2019: Timothy Ratliff, PhD, Purdue University Center for Cancer Research, “Contributions of Inflammation to Benign Prostate Hyperplasia”
  32. CROSS-DISCIPLINE INTERACTION: January 16, 2019: Lauren Michael, MS, UW-Madison Center for High Throughput Computing, “Accelerate Your Research with Scalable Computing: Resources on Campus and Beyond”
  33. CROSS-DISCIPLINE INTERACTION: December 19, 2018: Heidi Dvinge, PhD, UW Madison, Biomolecular Chemistry, “Prevalence and Function of Nuclear Receptor Isoforms in Cancer”
  34. December 12, 2018: Petra Popovics, PhD, Case Western Reserve University, “Molecular Links Between Chronic Inflammation and Benign Prostatic Hyperplasia”
  35. December 10, 2018: Hari Koul, PhD, LSUHSC, “Role of PDEF in Prostate Luminal Epithelium”
  36. November 14, 2018: Sara Roccabianca, PhD, Michigan State University, “Extracellular Matrix Remodeling in the Urinary Bladder Wall in Two Animal Models of Type 2 Diabetes”
  37. October 11, 2018: Marc Cox, MSPH, PhD, University of Texas at El Paso, “Molecular Chaperones and Cochaperones in Hormone-Dependent Physiology and Disease”
  38. October 10, 2018: Gerard Apodaca, PhD, University of Pittsburgh, “Umbrella Cells: Life in a Liquid Environment”
  39. CROSS-DISCIPLINE INTERACTION: October 3, 2018, Tony Goldberg, DVM, PhD, UW Madison, Pathobiological Sciences, “Metabiome of Male Lower Urinary Tract Syndrome: An Epidemiological and Ecological Study”
  40. September 12, 2108: Carolyn Best, PhD, American Urological Association, “The AUA and Urology Care Foundation: Providing Opportunities to Advance Urology Research”
  41. August 29, 2018: Andrey Shaw, PhD,Genentech Inc., “A Single Cell Sequencing View of the Glomerulus in Health and Disease”
  42. April 21, 2018: Heidi Wendell Brown, MD, UW-Madison, Department of OB/GYN, “Marketing Continence Promotion in the Community: The “Sell-ular” Level
  43. April 21, 2018: Tatyana Sysoeva, PhD, Duke University, “Regulation of Conjugative Transfer of B-lactam Resistance from Uropathogenic Strains of Escerichia Coli”
  44. April 21, 2018: Maryellen Kelly, CPNP, CNP, Duke University, “Diabetes and the Pediatric Lower Urinary Tract”
  45. April 21, 2018: Michael Wood, DVM, PhD, UW-Madison, Pathobiological Sciences, “Urothelial Response to Targeted Soluble and Membrane Bound IL-6 Signaling”
  46. April 21, 2018: Miguel Verbitsky, PhD, Columbia University, “Large-scale CNV Analysis Provides Insight Into the Genomic Architecture of Congenital Anomalies of the Kidney and Urinary Tract”
  47. INTERACTION WITH MAYO O’BRIEN CENTER: April 21, 2018: Marcelino Rivera, MD, Mayo Clinic, “Improving Stone Disease Treatment by Accurate Phenotyping and Risk Stratification”
  48. April 21, 2018: Dale Bjorling, DVM, UW-Madison, School of Veterinary Medicine, “What Can the UW-Madison/U Mass-Boston O’Brien Center Do For You?”
  49. April 20, 2018: Brian Van Le, MD, UT Southwestern, “Current Paradigms for Understanding and Managing Benign Prostatic Hyperplasia”
  50. April 20, 2018: Douglas Strand, PhD, UT Southwestern, “A Cellular Atlas of the Human Prostate”
  51. April 20, 2018: Will Ricke, PhD, UW-Madison, Department of Urology, “Identification of Cell Types and Pathways in Normal and Disease States”
  52. April 20, 2018: Jill Macoska, PhD, University of Massachusetts-Boston, “CXCL12/CXCR4-Mediated Procollagen Secretion is Coupled to Cullin-RING Ubiquitin Ligase Activation”
  53. CROSS-DISCIPLINE INTERACTION: April 20, 2018: Jacques Galipeau, MD, UW-Madison, Hematology/Oncology, “Translational Use of MSCs in Urology”
  54. CROSS-DISCIPLINE INTERACTION: April 20, 2018: Alejandro Roldán-Alzate, PhD, UW-Madison Departments of Mechanical and Biomedical Engineering, “Urinary Flow Dynamics in BPH – Effects of Bladder Neck Angle”
  55. April 20, 2018: Chad Vezina, PhD, UW-Madison, Department of Comparative Biosciences, “A Genetic Toolbox to Spy on Mouse Prostate Stromal Cells in Situ”
  56. April 20, 2018: Li Xin, PhD, Baylor University, “Inflammation and Prostate Epithelial Lineage Hierarchy”
  57. INTERACTION WITH GRADUATE TRAINEE:April 20, 2018: Mark Cadena, UW-Madison PhD Candidate, “Neuroendocrine Cells: Mediators of Prostate Smooth Muscle Contractility”
  58. CROSS–DISCIPLINE INTERACTION:April 20, 2018: Sheena Kerr, UW-Madison, Department of Biomedical Engineering, “Development of a Microscale Organotypic Model of Prostate Cancer”
  59. April 20, 2018: Paul Marker, PhD, UW-Madison, School of Pharmacy, “Modeling and Treating Fibrosis in the Urinary Tract”
  60. INTERACTION WITH UW-MADISON K12:April 20, 2018, Teresa Liu, PhD, K12 Scholar, UW-Madison, “Altered Steroidogenesis on Estrogen Receptor Activation in Benign Prostatic Hyperplasia”
  61. INTERACTION WITH GRADUATE TRAINEE:April 20, 2018, Sam Thomas, PhD Candidate, UW-Madison METC Program, “Proteomics by Mass Spectrometry for Molecular Insights into Hormone-Induced Lower Urinary Tract Dysfunction in Mice”
  62. INTERACTION WITH GRADUATE TRAINEE:April 20, 2018, Hannah Ruetten, PhD Candidate, UW-Madison Comparative Biomedical Sciences Program, “Impact of Age and Castration on Prostate Collagen Organization”
  63. INTERACTION WITH U.PITTSBURGH O’BRIEN CENTER: April 20, 2018: Zhou Wang, PhD, University of Pittsburgh, “Inflammation, Androgen Signaling, and Luminal Epithelial Barrier Dysfunction in BPH”
  64. March 7, 2018: Jianghui Hou, PhD, Washington University, “MicroRNA, Kidney, and Bladder Diseases”
  65. October 11, 2017: Charles Bieberich, PhD, University of Maryland, “Pelvic Pain, Proliferation, and PIN: Consequences of Chronic Prostatic Inflammation in a Mouse Model”
  66. INTERACTION WITH UW-MADISON K12:May 24, 2017, Heidi Wendell Brown, MD, K12 Scholar, UW-Madison, “How SHAIP is Shaping Up”
  67. INTERACTION WITH COLUBMIA O’BRIEN CENTER: May 24, 2017, Jonathan Barasch, MD, PhD, Columbia University, “An Iron Defense Against UTI”
  68. May 24, 2017: Lindsay Hampson, MD, UCSF, “Improving Transitional Urology Care”
  69. May 24, 2017: Adriane Sinclair, PhD, UCSF, “Analysis of Gene Expression in Human Penile Development”
  70. INTERACTION WITH U.PITTSBURGH O’BRIEN CENTER: May 24, 2017, Laura Pascal, PhD, University of Pittsburgh, “E-cadherin Downregulation and Increased Luminal Epithelial Permeability in BPH”
  71. May 24, 2017: Adam Szafran, MD, PhD, Baylor College of Medicine, “Using Cellular Imaging to Investigate the Role of Nuclear Receptor Expression and Mitochondria in Hypospadias”
  72. May 24, 2017: Mike Wood, DVM, PhD, DACVIM, UW-Madison, Department of Medical Sciences, “Calssic IL-6 Signaling Mitigates Urothelial Infection”
  73. CROSS–DISCIPLINE INTERACTION: May 24, 2017, Diego Hernando, PhD, UW-Madison, Department of Radiology and Medical Physics, “Quantitative MRI Techniques for the Assessment of BPH: Background and Proposed Research”
  74. May 24, 2017: Lisa Abler, PhD, UW-Madison, Department of Comparative Biosciences, “Deciphering the Influence of Diabesity and Intermittent Hypoxia on the Male Environment in Urinary Tract Dysfunction”
  75. May 23, 2017: Dolores Lamb, PhD, HCLD, Baylor College of Medicine, “Exploring Novel Alterations in Steroid Hormone Receptor Signaling that Underlie Human Congenital Genitourinary Anomalies”
  76. CROSS-DISCIPLINE INTERACTION: May 23, 2017: Joan Jorgensen, DVM, PhD, UW-Madison, Department of Pharmacology, “Development of Individual Male Urogenital Tract Components Require Distinct Threshold Concentrations of Fetal Testosterone”
  77. May 23, 2017: Larry Baskin, MD, UCSF, “Hormonal Control of Genital Development”
  78. May 23, 2017: Fred Vom Saal, PhD, University of Missouri, “Estradiol and Estrogenic Chemicals Modulate Androgen Action During Prostate Development”
  79. May 23, 2017: Paul Cooke, PhD, University of Florida, “Role of Membrane Estrogen Receptor 1 in the Development and Function of the Male Reproductive Tract”
  80. May 23, 2017: Chad Vezina, PhD, UW-Madison, Department of Comparative Biosciences, “Pinpointing Cellular Origins and Physiological Consequences of Prostate Fibrosis”
  81. INTERACTION WITH GRADUATE TRAINEE:May 23, 2017, David Lung, PhD Candidate, UW-Madison McArdle Cancer Biology Program, “Investigating the Mechanism of Estrogen Receptor α Regulation by Paracrine Interactions”
  82. May 23, 2017: Brett Johnson, MD, UW-Madison, Department of Urology, “One in Six Hypogonadal Men Treated with Clomiphene Citrate Need Combination Therapy with an Aromatase Inhibitor”
  83. INTERACTION WITH UNIVERSITY OF PITTSBURGH O’BRIEN CENTER: May 23, 2017: Don DeFranco, PhD, University of Pittsburgh, “Opposing Roles for Cox-2 in Regulating Estrogen Receptor Beta Function in the Prostate”
  84. CROSS–DISCIPLINE INTERACTION: May 23, 2017, Linda Schuler, VMD, PhD, UW-Madison, Department of Comparative Biosciences, “Hormone-ECM Collusion in Breast Cancer”
  85. May 23, 2017: Lisa Arendt, PhD, UW-Madison, Department of Comparative Biosciences, “Obesity and Erα: Selecting for Hormonal Responsiveness?”
  86. INTERACTION WITH GRADUATE TRAINEE: May 23, 2017: Diya Binoy Joseph, PhD Candidate, UW-Madison Cellular and Molecular Biology Program, “Harnessing Lineage Tracing to Study Hormonal Responses in the Prostate”
  87. CROSS-DISCIPLINE INTERACTION: May 23, 2017: Elaine Alarid, PhD, UW-Madison, Department of Oncology, “Postranslational Dynamics of ER and Its Paradoxical Roles in Cancer”
  88. CROSS–DISCIPLINE INTERACTION: May 23, 2017, Pamela Kreeger, PhD, UW-Madison, Department of Biomedical Engineering, “Computational Modeling of Cell Signaling Networks”
  89. May 23, 2017: Clara Jeong, PhD, UW-Madison, Department of Urology, “Measurement of Multi-steroid Hormones in Mouse Serum using LC-MS/MS”
  90. INTERACTION WITH GRADUATE TRAINEE:May 23, 2017, Kyle Helzer, PhD Candidate, UW-Madison McArdle Cancer Biology Program, “Investigating the Effects of Phosphorylation on the DNA Binding Properties of Erα”
  91. May 22, 2017: Kyle Richards, MD, UW-Madison, Department of Urology, “BPH: Androgens, Estrogens, and Fibrosis”
  92. May 22, 2017: Paul Marker, PhD, UW-Madison, School of Pharmacy, “Opportunities and Challenges for Modeling BPH and LUTS in Rodents”
  93. INTERACTION WITH GRADUATE TRAINEE:May 22, 2017, Sam Thomas, PhD Candidate, UW-Madison METC Program, “Mass Spectrometry-based Urinary Proteomics”
  94. INTERACTION WITH UW-MADISON K12:May 22, 2017, Alejandro Roldán-Alzate, PhD, K12 Scholar, UW-Madison, “Urinary Flow Dynamics – An MR Based Computational Modeling Approach”
  95. May 22, 2017: Claus Roehrborn, MD, UT Southwestern, “Steroid Hormones and Clinical LUTS/BPH: Correlations, Causations and Therapeutic Targets”
  96. May 22, 2017: Jill Macoska, PhD, University of Massachusetts-Boston, “Role of G-Protein Coupled Receptors in Lower Urinary Tract Fibrosis”
  97. CROSS-DISCIPLINE INTERACTION: May 22, 2017: Wei Xu, PhD, UW-Madison, Department of Oncology, “Next Generation ER and AR Blockers for Cancer Treatment”
  98. INTERACTION WITH UW-MADISON K12:May 22, 2017, Teresa Liu, PhD, K12 Scholar, UW-Madison, “Identification of Estrogen Regulated Gene Networks in BPH”
  99. CROSS-DISCIPLINE INTERACTION: May 22, 2017: Paul Lambert, PhD, UW-Madison, Department of Oncology, “Hormone Action in the Cervix”
  100. May 22, 2017: Will Ricke, PhD, UW-Madison, Department of Urology, “What is BPH and What Roles Might Estrogen Be Playing?”
  101. INTERACTION WITH GRADUATE TRAINEE:May 22, 2017, Molly Morgan, PhD Candidate, UW-Madison METC Program, “Reconstructing the Tissue Microenvironment to Understand the Role of Estrogens in Prostate Disease Progression”
  102. May 22, 2017: Stephen Hammes, MD, PhD, University of Rochester, “Steroids and Inflammation: How Studying Androgen Signaling Leads to the Neutrophil”
  103. May 22, 2017: Jun Luo, PhD, Johns Hopkins Medical Center, “Androgen Receptor Splice Variants: From Biology to Utility”
  104. INTERACTION WITH GRADUATE TRAINEE:May 22, 2017, Dalton McLean, PhD Candidate, “Androgen Regulation of FGF5 and its Role in the Prostate”
  105. May 22, 2017: Jim Dalton, PhD, University of Michigan, “Selective Androgen Receptor Modulators (SARMs) as Prostate-sparing Anabolic Therapy”
  106. March 8, 2017:Praveen Thumbikat, DVM, PhD, Northwestern University, “Mast Cells are Potential Mediators of Lower Urinary Tract Dysfunction”
  107. December 14, 2016: Scott Dehm, PhD, University of Minnesota Masonic Cancer Center, “Truncated AR Variants and Resistance to AR-targeted Therapies”
  108. November 9, 2016: Donald Vander Griend, PhD, University of Chicago, “Prostate Disease and Prostate Development: The Role of Sox2 and Atomic Bombs”
  109. INTERACTION WITH UW-MADISON K12:December 10, 2016, Teresa Liu, PhD, K12 scholar, “The role of estrogen receptor activation on BPH progression”
  110. October 12, 2016: Maria Hadjifrangiskou, PhD, Vanderbilt University, “Oxygen Mediates Biofilm Formation in Uropathogenic E.Coli In Vitro and In Vivo”
  111. September 14, 2016: Omar Franco, MD, PhD, NorthShore University, “Understanding the ‘Cancer Village’ – A Practical Approach to Study Cellular Heterogeneity in Cancer”
  112. May 12, 2016,  Jay Reeder, University of Rochester, “The Role of SCN9A in Pain Perception and Interstitial Cystitis”
  113. INTERACTION WITH EXTERNAL ADVISORY COMMITTEE (SITE VISIT):May 11, 2016, Mark T. Nelson, PhD, University Distinguished Professor and Chair, Department of Pharmacology, University of Vermont, “Non-Voiding Contractions Encode Essential Information on Urinary Bladder Fullness”
  114. INTERACTION WITH UW-MADISON K12:April 14, 2016,  Michael Wood, K12 Scholar, UW-Madison, “Barrier Function in Bladder Disease”
  115. INTERACTION WITH UW-MADISON K12:April 5, 2016, Teresa Liu, PhD, K12 Scholar, UW-Madison, “Selective Estrogen Receptor Modulators and BPH”
  116. INTERACTION WITH GRADUATE TRAINEE:April 5, 2016, Megan Livingston, UW-Madison, “Utilizing Micro-scale Tools to Identify Key Factors in the Microenvironment”
  117. CROSS–DISCIPLINE INTERACTION:April 5, 2016, Wei Xu,PhD, UW-Madison, Department of Oncology, “Direct Estrogen Receptor Dimerization Using Chemical Probes”
  118. INTERACTION WITH GRADUATE TRAINEE:April 5, 2016, Diya Binoy Joseph, UW-Madison, “Investigating the Role of DNA Methylation in Prostate Development and Disease”
  119. CROSS–DISCIPLINE INTERACTION:April 5, 2016, John Denu, UW-Madison, Department of Biomolecular Chemistry, “Histone-typing as an Epigenetic Tool in Diagnosis and Treatment”
  120. INTERACTION WITH EXTERNAL ADVISORY COMMITTEE (SITE VISIT):April 5, 2016, Shuk-Mei Ho, University of Cincinnati, “BPA Effects on Methylation in Reproductive Tissues”
  121. CROSS–DISCIPLINE INTERACTION:April 5, 2016, Linda Schuler, UW-Madison, “Desmoplasia: Hijacking Hormones in Breast Cancer”
  122. INTERACTION WITH GRADUATE TRAINEE:April 4, 2016, Kyle Wegner, UW-Madison, Department of Comparative Biosciences, “Picrosirius Red: A Versatile Tool for Analyzing Collagen in the Lower Urinary Tract”
  123. April 4, 2016, Allison Brodbeck, UW-Madison “Ultrasound Imaging of the Mouse Renal System”
  124. April 4, 2016, Lingjun Li, UW-Madison, “Developing Mass Spectrometry-based Omics Strategies for Candidate Biomarker Discovery in LUTS”
  125. INTERACTION WITH GRADUATE TRAINEE:April 4, 2016, Justine Coburn, UW-Madison, “ER and AhR Crosstalk in Breast Cancer”
  126. CROSS–DISCIPLINE INTERACTION:April 4, 2016, Weiping Tang, UW-Madison, “The Next Generation of SAhRM as Potential Therapeutics”
  127. INTERACTION WITH GRADUATE TRAINEE:April 4, 2016, Jordan Vellky, UW-Madison, “BPA Exposure and Associated Gene Expression Changes in Prostate Cancer“
  128. INTERACTION WITH GRADUATE TRAINEE:April 4, 2016, Jalissa Wynder, UW-Madison, “The Role of Bisphenol A in LUTD”
  129. April 4, 2016, Barry Timms, University of South Dakota, “The Role of Bisphenol-A in LUTDevelopment and LUTD”
  130. CROSS NIH INSTITUTE INTERACTION:April 4, 2016, Rick Woychik, Deputy Director, NIEHS,“Toxicological Insights for Future Research.
  131. April 4, 2016, Reginald Bruskewitz, UW-Madison, “Overview of BPH/LUTS: A Role for Compliance and Fibrosis”
  132. INTERACTION WITH TRAINEES:March 10, 2016, (mini-talks from Lisa Abler(scientist), Kyle Wegner (graduate student), Mark Cadena (Graduate Student) and Royal Oakes (Undergraduate)), “Urologic Research Tools in Development”
  133. INTERACTION WITH FORMER P20 CENTER:March 8, 2016, Anna Malykhina, PhD, Associate Professor of Urology University of Colorado School of Medicine, The Role of Neural Circuits in Regulation of Lower Urinary Tract Function”
  134. February 10, 2016, Lingjun Li, PhD, Professor of Pharmaceutical Sciences and Chemistry, University of Wisconsin-Madison, “Developing Mass Spectometry-based Omics Strategies for Candidate Biomarker Discovery in Lower Urinary Tract Symptoms (LUTS) and Beyond”
  135. INTERACTION WITH FORMER WASHINGTON UNIVERSITY P20 CENTER:January 13, 2016, Jeffrey H. Miner, PhD, FASN, Professor of Medicine and of Cell Biology and Physiology, Washington University School of Medicine, “Roles of Basement Membranes in the Urogenital System”
  136. January 14, 2016, Neil Lamarre(Post-doctoral Fellow, Dale Bjorling Lab), “Relevance of Lower Urinary Tract Function Testing in Mice to Humans”
  137. January 11, 2016: Jianfeng Xu, MD, DrPH, NorthShore University, “Pyramid Model for Precision Medicine of Cancer: Genomic-based Individualized Cancer Care from Prevention and Screening to Diagnosis and Treatment”
  138. INTERACTION WITH MAYO O’BRIEN CENTER:December 9, 2015, Michael F. Romero, PhD, Professor of Physiology & Biomedical Engineering and Nephrology & Hypertension, Mayo Clinic College of Medicine, “The Electrogenic Na+ Bicarbonate Cotransporter (NBCe1) – metabolic acidosis and glaucoma”
  139. October 14, 2015, Douglas Strand, PhD, UT Southwestern Medical Center, “Dissecting the Pathogenesis of Clinical BPH”
  140. May 6, 2015, Teresa Liu, PhD, University of Pittsburgh, “5α-reductase inhibition drives production of Erβ ligands via a COX-2 dependent mechanism in BPH”
  141. INTERACTION WITH COLUMBIA O’BRIEN CENTER:April 10, 2015; Cathy Mendelsohn, Professor of Urology, Pathology & Cell Biology,(Institute of Human Nutrition) and Genetics & Development, U54 O’Brien Urology Research Center Director, Columbia University, “Progenitors important for formation and regeneration of the urothelium, and their contribution to bladder cancer”
  142. April 9, 2015; Kevin Elicieri, UW-Madison, “Multiscale Imaging Approaches for Investigating ECMChanges in Disease”
  143. April 9, 2015; Wei Huang, UW-Madison, “Characterization of Fibrillar Collagens and Extracellular Matrix of Glandular Benign Prostatic Hyperplasia Nodules”
  144. April 9, 2015; Ben Humphreys, Harvard, “Resident Perivascular Cells and Organ Fibrosis”
  145. CROSS–DISCIPLINE INTERACTION:April 8, 2015; Paul Campagnola, UW-Madison, “High Resolution Imaging and Modeling Approaches to Study ECM Changes in Cancer, Fibrosis, and Connective Tissue Disorders”
  146. CROSS–DISCIPLINE INTERACTION:April 8, 2015; Linda Schuler, UW-Madison, “Matric Stiffness: Recruitment of Hormones to the Dark Side of Breast Cancer”
  147. CROSS–DISCIPLINE INTERACTION:April 8, 2015; Patricia Keely, UW-Madison, “Molecular changes of fibrosis during mammary gland pathogenesis”
  148. CROSS NIH INSTITUTE INTERACTION:April 8, 2015; Tom Wynn, NIAID, “Targeting immunological mechanisms of fibrosis”
  149. April 8, 2015; Jill Macoska, UMASSBoston, “CXCL12-mediated non-canonical signaling promotes myofibroblast phenoconversion in the prostate”
  150. March 9, 2015; Gail Risbridger, Professor, Director of Centre for Urologic Research and Monash University, “Patient Derived Xenografts: Preclinical Insights that Influence Clinical Practice”
  151. February 18, 2015; Rosalyn Adam, PhD, Harvard University, “Signaling networks in the bladder: implications for benign urologic disease”
  152. January 21, 2015; Simon W. Hayward, PhD, Vanderbilt University, “Inflammation and androgen receptor variant expression in benign prostatic hyperplasia”

SERVICE & LEADERSHIP

Scientific Organizations – positions held

WORKSHOPS

  • 2018 August, Faculty Instructor, Workshop on Techniques in Modeling Human Cancer in Mice, The Jackson Laboratory, Bar Harbor MA, Chad Vezina

COMMITTEES

  • 2018, Trainee Affairs Committee Member, Society of Basic Urologic Research (SBUR), Chad Vezina
  • 2018, Finance Committee Member, Society of Basic Urologic Research (SBUR), Chad Vezina
  • 2017-present, Research, Education, Conferences, Communications (RECCC) Committee, AUA, Member, Will Ricke
  • 2016, Program Committee, American Urological Association (AUA) Summer Research Conference “Targeting Epigenetics and Genome Regulation to Improve Urologic Health”, Lithicum, MD, Chad Vezina
  • 2016, Session Chair, Epigenetic Considerations for Bladder Dysfunction & Pain Syndromes, American Urological Association (AUA) Summer Research Conference “Targeting Epigenetics and Genome Regulation to Improve Urologic Health”, Lithicum, MD, Chad Vezina
  • 2016, Chair, Organizing Committee, 2016 Basic Science Symposium, American Urological Association Annual Meeting, San Diego, CA, Jill Macoska
  • 2015, Planning committee, Society for Basic Urologic Research (SBUR) Fall Meeting, Chad Vezina
  • 2015, Session Chair, Discussion Forum: Emerging Model Systems for Research. SBUR Fall Symposium, F. Lauderdale, FL, Chad Vezina
  • 2015, Session Chair, Cell-Specific Responses to Comorbidities in BPH. SBUR Fall Symposium, Ft. Lauderdale, FL, Chad Vezina
  • 2014-present, U54 Symposium Organizing Committee, Chair, Will Ricke
  • 2014-present, University of Wisconsin Molecular Environmental Toxicology Center, Steering Committee, Will Ricke
  • 2014-present, University of Wisconsin George M. O’Brien Center, Steering Committee, Will Ricke
  • 2014-present, University of Wisconsin George M. O’Brien Center, Senior Executive Committee, Will Ricke
  • 2014, American Urological Association Office of Research, Representative, Will Ricke
  • 2014, NIDDK Centers, Norm Braveman Inc. – Future of Benign Urology, Consultant, Will Ricke
  • 2012-2016, Awards Committee, Society of Basic Urologic Research, Will Ricke
  • 2011-2016, Abstraction Selection Committee, Society of Basic Urologic Research, Will Ricke 

BOARDS

  • 2018, President Elect, Midwest regional chapter, Society of Toxicology, Chad Vezina
  • 2015, Past-President, the Society for Basic Urologic Research, Jill Macoska
  • 2014, President, the Society for Basic Urologic Research, Jill Macoska
  • 2014-present, American Journal of Physiology – Renal, Editorial Board, Chad Vezina
  • 2013-present, American Journal of Clinical and Experimental Urology, Editorial Board, Chad Vezina
  • 2012-present, The Prostate, Editorial Board, Jill Macoska
  • 2012-present, The Bladder, Editorial Board, Jill Macoska

MODERATOR

  • 2017, Invited Subject Matter Expert, responsible for creating an online training module for NIH K-series career development awards for the American Urological Association (AUA), Chad Vezina
  • 2015, NIDDK Meeting, Baltimore, MD, Chad Vezina
  • 2015, NIDDK Centers Meeting, Baltimore, MD, Will Ricke
  • 2015, AUA Meeting, New Orleans, LA, Will Ricke
  • 2014, P20 Centers Directors Meeting Update, Pacific Grove, CA, Will Ricke
  • 2014, Great Lakes Nuclear Receptor Meeting, Madison, WI, Will Ricke

GRANT REVIEW ACTIVITIES

  • 2018, Member, Review Panel, ZDK1-GRB-3 George M. O’Brien Urology Cooperative Research Centers Program (U54), Jill Macoska
  • 2018, Member, Review Panel, ZDK-GRB-S (M3), NIDDK Central Repository X01, Jill Macoska
  • 2018, Member, Review Panel, ZCA1 SRB-2, NCI CPACHE U54 and P20, Jill Macoska
  • 2018, Member, Review Panel, ZDK1 GRB-03 (01) U54 Urology Research Center Applications, Jill Macoska
  • 2018, NIH ZDK1 GRB-6 (O2), P01 Application Urinary Tract Dysfunction, Dale Bjorling
  • 2018, NIH ZDK1 GRB-M (O1), P01 Application Bladder Physiology, Dale Bjorling
  • 2018, NIH Special Emphasis Panel ZRG1 IMST-D (80), Dale Bjorling
  • 2018, USDA NCAC-02 program review,Dale Bjorling
  • 2017, NIH Special Emphasis Panel ZDK1 GRB-M (O2), Dale Bjorling
  • 2017, NIH Panel ZRG1 IMST-U (80), Dale Bjorling
  • 2017, Department of Defense, Urological Disorders, PRMPR program, Dale Bjorling
  • 2016, Member, NIH/NIDDK Review Panel, 2016/10 ZRG1 DKUS-G (90) S Urologic and Urogynecologic Applications, Jill Macoska
  • 2016, Member, NIH/NIDDK Review Panel, 2016/10 ZDK1-GRB-3 (O2) 1 George M. O’Brien Urology Cooperative Research Centers Program (U54), Jill Macoska
  • 2016, Member, NIH/NIDDK Review Panel, George M. O’Brien Urology Cooperative Research Centers Program (U54) NIH/NIDDK Review Panel, ZDK-GRB-S (M3), Jill Macoska
  • 2016, NIH/NIDDK Special Emphasis Review Panel ZRG1 DKUS-G (90) S, Chad Vezina
  • 2016-2019, Standing Member, NIH/NIDDK DDK-D Panel, Chad Vezina
  • 2016, NIH ZDK1 GRB-2 (M3) GUDMAP RFA, Dale Bjorling
  • 2015-2018, University of Wisconsin-Madison ICTR/CTSA Pilot Awards Review, Will Ricke
  • 2015, NIH/NIDDK Special Emphasis Review Panel ZDK1 GRB-S (O4), Chad Vezina
  • 2015, Member, Review Panel, NIH/NIDDK ZDK1 GRB-3 (01), U54 Urology Research Center Applications, Jill Macoska
  • 2015, 2016, NIH/NIDDK DDK-D Subcommittee (Kidney, Urological and Hematological, review of career development awards), Chad Vezina
  • 2015-2017, Department of Veterans Affairs Review Panel 10P9B/SURG, Chad Vezina
  • 2015, NIH Special Emphasis Panel ZRG1 DKUS-N (90), Dale Bjorling
  • 2014, Member, Review Panel, NIH/NIDDK ZDK1 GRB-S (O5), Novel Methods for Measurement of Organ Fibrosis (U01), Jill Macoska
  • 2014, Member, Review Panel, NIH/NIDDK ZDK1 GRB-S (M1), NIDDK Central Repositories Non-Renewable Sample Access, Jill Macoska
  • 2014, NIH/NIDDK Urological and Urogynecological Sciences and Small Business Special Emphasis Panel, NIH/NIDDK ZRG1 DKUS-G (90), Dale Bjorling
  • 2014-present, University of Wisconsin George M. O’Brien Center Pilot Project Program, Chair, Will Ricke
  • 2014-2017, University of Wisconsin-Madison Molecular and Environmental Toxicology Center Grad Student Training Grant Selection, Will Ricke
  • 2014-2017, University of Wisconsin-Madison Molecular and Environmental Toxicology Postdoctorate Training Grant Selection, Will Ricke
  • 2016, ZCA1 RPRB-N (J1), P01 NCI Program Project Review III, Will Ricke
  • 2016, ZCA1 RPRB-7(01) SPORE Review II, Will Ricke
  • 2017, ZCA1 RPRB-7(M1) NCI SPORE II Review, Will Ricke
  • 2017, ZDK1 GRB-3(02) Developmental Centers in Benign Urology (P20), Will Ricke
  • 2018, NIH/NIDDK Special Emphasis Review Panel ZRG1-DKUS-B(90) R01, Will Ricke

NIH COUNCIL

  • 2019, Ad-HocMember, NIDDK Advisory Council, Jill Macoska

GRANT APPLICATIONS

Funded:

  1. 5K12DK100022 (Bjorling, Dale E. (PI) & Bushman, Wade A. (Co-PI)), 2013-2023, NIH/NIDDK, $868,311 (2017-2018) then $628,217/yr (2018-2023). Wisconsin Multidisciplinary K12 Urologic Research Career Development Program. Funded.
  2. R01 DK099328 (Vezina, Chad M.), 2014-2019, NIDDK, $327,338. Role of DNA Methylation in Prostate Glandular Development and Urinary Function. Funded.
  3. 5 U54 DK104310-02 (Ricke, William A.), 9/24/14-7/31/19, NIDDK, $7,188,701. Mediators of Fibrosis in the Development of Lower Urinary Tract Dysfunction. Funded.
  4. 3 U54 DK104310 02S1 (Ricke, William A.), 2015, NIDDK, $50,000. Mediators of Fibrosis in the Development of Lower Urinary Tract Dysfunction. Funded.
  5. 2R01 DK077195-06 (Adam, PI) (Macoska, Co-INV), 08/07/15 – 04/30/19, NIH/NIDDK, $56,207 DC/year. Mechanotransduction In Bladder Smooth Muscle. Funded.
  6. 3 U54 DK104310 03S1 (Ricke, William A.), 2016, NIDDK, $103,761. Mediators of Fibrosis in the Development of Lower Urinary Tract Dysfunction. Funded.
  7. 2P30CA014520-44 PILOT (Ricke, William A.), 2016, NCI, $12,500 direct. Identification of DDX3-RNA Binding Protein mRNAs in Prostate Cancer: Potential Roles in Castration Resistant Prostate Cancer. PILOT for U54. Funded.
  8. U54 DK104310 PILOT (Goldberg, Tony; Li, Lingjun; Penniston, Kristina), 2016, NIDDK, $150,000. Functional Metabiome of Lower Urinary Tract Syndrome. Funded.
  9. U54 DK104310 PILOT (VanderHorst, Veronique), 2016, NIDDK, $150,000. Neural Plasticity in Bladder outlet Obstruction. Funded.
  10. U01DK110807 (Vezina, Chad M., PI), 9/15/2016-5/31/2021, NIH/NIDDK, $179,728. Molecular and Fate Maps of Prostatic Stroma. Funded.
  11. U54 CA156734 (Colon-Carmona, PI; Macoska, Co-PI), 09/01/16-08/31/21, NIH/NCI, $6,671,664 (total DC). (1/2) The University of Massachusetts, Boston – Dana-Farber/Harvard Cancer Center U54 Comprehensive Partnership for Cancer Disparities Research. Funded.
  12. W81XWH-16-1-0246 (Neuman, Sarah), 2016-2019, DoD/Army, $191,250. Effects of Phthalates on Androgen Receptor Regulation Associated with Castration-Resistant Prostate Cancer Development. Funded.
  13. 3 U54 DK104310 04S1 (Ricke, William A.), 2017, NIDDK, $99,203. Mediators of Fibrosis in the Development of Lower Urinary Tract Dysfunction. Funded.
  14. R01ES001332 (Peterson, Richard & Vezina, Chad M. (Co-PIs)), 08/01/2017-07/31/2022, NIH/NIEHS, $308,554 DC/year. Reproductive and Developmental Toxicity of Dioxin. Funded.
  15. U01DK110807-02S1 Supplement (Vezina, Chad M., PI), 06/01/2017 – 05/31/2018, NIH/NIDDK, $65,741. Role of Prostate Neuroendocrine Cells in Homeostatic Regulation of Prostate Stroma. Funded.
  16. R01CA204320 (Shull, Jim (PI), Vezina, Chad M. (Co-PI)), 1/1/2017-12/31/2018, NIH/NCI, $323,058 DC/year. Characterization of Emca4, the Rat Ortholog of the 8q24 Breast Cancer Risk Locus. Funded.
  17. F31ES028594-01A1 (Wegner, Kyle (PI) & Vezina, Chad M. (Co-PI)) 7/1/2017-6/30/2020, NIH/NIEHS, $31,466 DC/year. TCDD reprograms prostate stroma and causes fibrosis to induce urinary dysfunction. Funded.
  18. 5 R01 CA213293-02 (Xu, Wei), 2017-2022, NIH/NCI, $104,576. Protein Arginine Methylation in Chemotherapy Resistance. Funded.
  19. R01HD090660-01A1 (Theberge, Ashleigh), 2017-2022, NICHD, $353,209. Mediators for Dynamic Regulation of Star Transcription: Comparing Fetal and Adult Leydig Cells. Funded.
  20. 1UG3TR002158-01 (Theberge, Ashleigh), 2017-2019, NCATS & NIDDK, $46,574. A Microphysiological System for Kidney Disease Modeling and Drug Efficacy Testing. Funded.
  21. Kavli Microbiome Ideas Challenge Award (ASM, ACS & APS) (Theberge, Ashleigh), 2017-2018, Kavli Microbiome Ideas Challenge Award, $340,000. Deciphering Multikingdom Communication Molecules Using Engineered Cellular Traps. Funded.
  22. 3 U54 DK104310 05S1 (Ricke, William A.), 2018, NIDDK, $590,619. Mediators of Fibrosis in the Development of Lower Urinary Tract Dysfunction. Funded.
  23. 5 U54 DK104310-04 REVISED (Ricke, William A.), 2018, NIDDK, $264,498. Mediators of Fibrosis in the Development of Lower Urinary Tract Dysfunction – Interaction Core Development. Funded.
  24. U54 DK104310-04S2 PILOT (Strand, Douglas W.), 2018, NIDDK, $121,500. Protocol Development for Single Cell RNA Sequencing of Human Prostate. Funded.
  25. T32 ES007015 (Bradfield, Christopher (PI) & Vezina, Chad M. (Co-PI, Deputy Director)), 7/01/2018-6/30/2023, NIH/NIEHS, $612,326 DC/year. Molecular & Environmental Toxicology Pre- and Postdoctoral Training Grant. Funded.
  26. R01 HD094759-01 (Hernandez, Laura (PI) & Vezina, Chad M. (Co-PI)),
  27. 07/20/2018 – 04/30/2023, NIH/NICHD, $214,283 DC for 2018-2019; Influence of SSRI Use During Pregnancy and Lactation on Maternal Bone Health. Funded.
  28. U54 CA156734 PILOT (Macoska, Jill A.), 2018-2019, NIH/NCI, $160,000 direct. Validation of Urinary RNA Biomarkers Predictive for RCC Diagnosis; Funded
  29. 1S10OD023526-01A1 (Ricke, William A.), 2018, NIH, $183,824. Automated Tissue Microarrayer. Funded.
  30. 2P30CA014520-44 (Bailey, Howard H.), 2018-2023, NCI, $4,590,130 TC for 2018. UW Comprehensive Cancer Center Support.
  31. R21 AI138255-01 (Jerde & Arrizabalaga & Strand, Douglas W.), 2018, NIH/NIAID, $234,528. Prostate Pathogenesis during Toxoplasma gondii Infection. Funded.
  32. R01 DK115477-01 (Strand, Douglas W.), 2018, NIH/NIDDK, $1,919,132. Notch-mediated 5ARI Resistance in Human BPH. Funded.
  33. TL-1 (Ruetten, Hannah & Vezina, Chad M.), 2018-2020, UW-Madison Clinical and Translational Research Center (IICTR), TL-1 Fellowship; $30,648 DC/year. Prostate Inflammation Drives Fibrosis and LUTD. Funded.
  34. S10 OD025084 01 (Li, Lingjun (PI) & Ricke, William A. (Co-PI)), 2018-2019, NIH, $598,208. Equipment Grant, Mass Spectrometry. Funded.
  35. 1R35GM128648-01 (Theberge, Ashleigh), 2018-2023, NIH, $1,927,520 TC. Deciphering the Role of Chemical Signals in Inflammation with Open Microfluidic Functional Assays. Funded.
  36. Arnold and Mabel Beckman Foundation (Theberge, Ashleigh), 2018-2020, Arnold and Mabel Beckman Foundation, $600,000 DC. Uncovering Chemical Signals in Complex Cellular Environments with Open Microfluidic Methods. Funded.
  37. 5 T35 DK062709 13 (Mezrich, Joshua), 2018, NIDDK, $50,144. Surgery Summer Research Experience for Medical Students; (Ricke, Trainer); Funded.
  38. R13 (Ricke, William A.), 2019, NIH, $15,000. Social and Antisocial Behavior of Cells in the Urinary Tract. Funded.
  39. 1R01DK120025-01 (Southard-Smith, Michelle & Bjorling, Dale E.), 2019, NIDDK, $382,499. Serotonin Signaling in Control of the Lower Urinary Tract. Funded.
  40. 5R21CA195313—02 (Marker, Paul C.),MAGI2 in Aggressive Prostate Cancer. Funded.

Pending:

  1. R01 DK118145 (Bjorling, Dale E. and Hou, J), 2019-2024. Regulation of Bladder Structure and Function by Micro-RNA29. NIH/NIDDK, $490,000 DC/year. 11thpercentile, awaiting Council meeting May 5, 2019.
  2. F31DKXXXXX (Turco, Anne & Vezina, Chad M.), 2019-2021, NIH/NIDDK, $31,466 DC/year. Developmental Origins of Prostate-Related Urinary Dysfunction in Adult Males: TCDD Exposure Increases Prostatic Noradrenergic Innervation and Smooth Muscle Contraction.
  3. W81XWH-18-PCRP-IDA PC170951 GRANT12511682 (Ricke, William A.), 2019-2022, DoD/Army, $917,988 TC. The RNA Binding Protein, Belle/DDX3, Binds Androgen Receptor RNA to Promote CRPC.
  4. R01 DK121505 A1, (Jerde, Travis), 2019-2024. NIH/NIDDK, $325,000 DC/year. Convergence of Interleukin and Steroid Signaling in Toxoplasma-induced Prostatic Hyperplasia. NAF=1; Indiana University.
  5. R01 DK123471-01, (MacIver, Ian), 2019-2024.NIH/NIDDK. Neural Mechanisms of Voiding Dysfunction in Benign Prostatic Hyperplasia (BPH). NAF=1; Harvard University. 

AWARDS

  • 04/2019, Diya Binoy Joseph (Vezina Lab), UW-Madison Cellular and Molecular Biology Graduate Program 2018 Exceptional Thesis Award
  • 03/2019, Phinea Romero, SPUUR Intern, Robert Gunn Student Award, American Physiological Society
  • 2019-present, Chad Vezina, Director, Molecular and Environmental Toxicology Center, University of Wisconsin-Madison
  • 2019, Kim Keil, PhD, 2019 Women in Toxicology Postdoctoral Achievement Award
  • 12/2018, Anne Turco, Research Associate (Vezina Lab), Society of Toxicology Supplemental Training for Education Program (STEP) Award
  • 12/2018, Chelsea O’Driscoll, Research Associate (Vezina Lab), Best Poster Award, Collaborating for the Advancement of Interdisciplinary  Research in Benign Urology (CAIRIBU) Meeting, Ellicott City, MD
  • 12/2018, Hannah Ruetten, Research Assistant (Vezina Lab), Best Poster Award, Collaborating for the Advancement of Interdisciplinary  Research in Benign Urology (CAIRIBU) Meeting, Ellicott City, MD
  • 11/2018, Dalton McLean, Graduate Student, Travel Award, SBUR, Palm Springs, CA: “Fibroblast Growth Factor-5 Increases Androgen Receptor Expression and Signaling in Prostate Cancer”
  • 10/2018, Anne Turco, Research Assistant (Vezina Lab), Eula and Donald S. Coffey Research Innovation Award, Society for Basic Urologic Research
  • 10/2018, Mark Cadena, Research Assistant (Vezina Lab), travel award to the 2018 Society for Basic Urologic Research Annual Meeting
  • 10/2018, Anne Turco, Research Assistant (Vezina Lab), travel award to the 2018 Society for Basic Urologic Research Annual Meeting
  • 10/2018, Kyle Wegner, Research Assistant (Vezina Lab), travel award to the 2018 Society for Basic Urologic Research Annual Meeting
  • 10/2018, Hannah Ruetten, Research Assistant (Vezina Lab), travel award to the 2018 Society for Basic Urologic Research Annual Meeting
  • 10/2018, Diya Binoy Joseph, Research Assistant (Vezina Lab), Cellular and Molecular Biology Travel Award
  • 04/2018, Hannah Ruetten, Research Assistant (Vezina Lab), Comparative Biomedical Sciences Spring Travel Award
  • 04/2018, Kyle Wegner, Research Assistant (Vezina Lab), Midwest Regional Chapter of the Society of Toxicology Young Investigator Award
  • 04/2018, Hannah Ruetten, Research Assistant (Vezina Lab), Institute of Clinical and Translational Research TL-1 clinical training grant
  • 03/2018, Kyle Wegner, Research Assistant (Vezina Lab), Eric Andreasen Memorial Award for Research Excellence
  • 03/2018, Kyle Wegner, Research Assistant (Vezina Lab), National Institutes of Health F31 Research Fellowship Award
  • 03/2018, Hannah Ruetten, Research Assistant (Vezina Lab), Comparative Biomedical Science Graduate Program Travel Award
  • 03/2018, Teresa Liu, K12 scholar (Ricke Lab), moderated poster session: “Altered steroidogenesis on estrogen receptor activation in benign prostatic hyperplasia”, ENDO, Chicago, IL
  • 2018, Ashleigh Theberge, former K12 Scholar (Ricke Lab), one of ten 2018 Beckman Young Investigator (BYI) Award recipients
  • 2018, Ashleigh Theberge, former K12 Scholar (Ricke Lab), NIH Maximizing Investigators’ Research Award (MIRA) for Early Stage Investigators (R35)
  • 2018, Jalissa Wynder (Nguyen), Post-doc (Ricke Lab), Burdock Group student travel award
  • 2018, Jalissa Wynder (Nguyen),Post-doc (Ricke Lab), Toxicologists of African Origin (TAO) travel award
  • 2018, Jalissa Wynder (Nguyen),Post-doc (Ricke Lab), Graduate Student Excellence Award from the Regulatory and Safety Evaluation Specialty Section (RSESS) of the Society of Toxicology
  • 11/2017, Kyle Wegner, Research Assistant (Vezina Lab), Society of Toxicology Supplemental Training for Education Program (STEP) Award
  • 09/2017, Diya Binoy Joseph, Research Assistant (Vezina Lab), Gregory F. Daniels Best Poster award, UW-Madison Stem Cell & Regenerative Medicine Center Fall Conference
  • 08/2017, Jordan Vellky, Graduate Student (Ricke Lab), Gordon Research Conference: Hormone-Dependent Cancers, Newry, ME: “Hormonal Modulation of DDX3 and its Implications for Translational Regulation in Prostate Cancer”
  • 08/2017, Jordan Vellky, Graduate Student (Ricke Lab), Funded by T32 Training Grant, Madison, WI
  • 08/2017, Dalton McLean, Graduate Student (Ricke Lab), Funded by T32 Training Grant, Madison, WI
  • 08/2017, Kyle Wegner, Research Assistant (Vezina Lab), Zaman-Saroya Award winner for excellence in research and scholarship (University of Wisconsin-Madison)
  • 08/2017, Anne Turco, Research Assistant (Vezina Lab), National Institutes of Health T32 training grant in Molecular and Environmental Toxicology
  • 08/2017, Diya Binoy Joseph, Scholar, Workshop on Epigenetics at the Van Andel Research Institute
  • 08/2017, Kyle Wegner, Research Assistant (Vezina Lab), cover art in J Histochem Cytochem
  • 07/2018, Mark Cadena, Research Assistant (Vezina Lab), two year research grant from the National Institutes of Health to support his studies of prostate neuroendocrine cells.
  • 04/2017, Stephen (Royal) Oakes, Undergraduate Researcher (Vezina Lab), Hilldale Undergraduate Research Fellowship
  • 02/2017, Anoop Chandrashekar, Undergraduate Researcher (Vezina Lab), National Merit Scholar Finalist
  • 2017, Ashleigh Theberge, former K12 Scholar (Ricke Lab), one of three worldwide recipients of the Kavli Microbiome Ideas Challenge Award (ASM, ACS & APS)
  • 2017, Jalissa Wynder (Nguyen),Post-doc (Ricke Lab), Invited Speaker at Southern University’s Wilbur B. Clarke Chemistry Symposium
  • 2017, Jalissa Wynder (Nguyen),Post-doc (Ricke Lab), ILSI North America Summer Fellow
  • 2017-present, William Ricke, CoLeader, Tumor Microenvironment, Senior Leadership-UW Carbone Cancer Center
  • 2017-present, William Ricke, Member, Research, Education, Conferences , Communications (RECC) Committee, American Urological Association
  • 11/2016, Dalton McLean, Graduate Student (Ricke Lab), Travel Award, SBUR, Scottsdale, AZ: “In vivo Modeling of Metastasis Using a Prostate Cancer Progression Model”
  • 09/2016, Mark Cadena, Research Assistant (Vezina Lab), Society for Basic Urologic Research Fall Meeting Travel Award.
  • 09/2016, Diya Binoy Joseph, Research Assistant (Vezina Lab), Society for Basic Urologic Research Fall Meeting Travel Award.
  • 09/2016, Diya Binoy Joseph, Research Assistant (Vezina Lab), Cellular and Molecular Biology Travel award
  • 09/2016, Stephen (Royal) Oakes, Undergraduate Researcher (Vezina Lab), UW-Madison College of Engineering Frederick J. Mancheski Scholarship
  • 09/2016, Diya Binoy Joseph, Research Assistant (Vezina Lab), American Urological Association Summer Research Conference Travel Award
  • 08/2016, Jordan Vellky, Graduate Student (Ricke Lab), Funded by T32 Training Grant, Madison, WI
  • 08/2016, Dalton McLean, Graduate Student (Ricke Lab), Funded by T32 Training Grant, Madison, WI
  • 05/2016, William Ricke, Plenary talk, American Urological Association, San Diego, CA
  • 05/2016, Chad Vezina, Zoetis Award for Veterinary Research Excellence 04/2016, Stephen (Royal) Oakes, Undergraduate Researcher (Vezina Lab), Sophomore Undergraduate Research Fellowship
  • 2016-present, William Ricke, Affiliate Associate Professor, Division of Pharmaceutical Sciences, University of Wisconsin-Madison School of Pharmacy
  • 2016-present, Ashleigh Theberge, former K12 Scholar (Ricke Lab), Assistant Professor of Chemistry and Adjunct Assistant Professor of Urology, University of Washington
  • 2016-present, Chad Vezina, Director, Summer Program in Undergraduate Urologic Research (SPUUR), University of Wisconsin-Madison
  • 11/2015, Jordan Vellky, Graduate Student (Ricke Lab), Travel Award, SBUR, Ft. Lauderdale, FL: “BOP1 Expression and Localization in Benign Prostatic Disease and Prostate Cancer Progression”
  • 06/2015, Helene Altmann, Undergraduate Researcher (Vezina Lab), Promega International Scientific Internship Scholarship
  • 06/2015, Bill Mulligan, Undergraduate Researcher (Vezina Lab), Barry Goldwater Federal Scholarship
  • 06/2015, Bill Mulligan, Undergraduate Researcher (Vezina Lab), Rhoades Scholarship Finalist
  • 06/2015, Helene Altmann, Undergraduate Researcher (Vezina Lab), Covance Laboratories Pharmacology and Toxicology Excellence Award
  • 02/2015, William Ricke, Associate Professor, Clark-Atlanta University Lecture, Atlanta, GA, Graduate student and postdoc association, “Hormone action and paracrine interactions in prostatic carcinogenesis”
  • 2015, Tristan Nicholson, former Graduate Student (Ricke Lab), MD with Distinction in Research, PhD Pathology, University of Rochester School of Medicine and Dentisry
  • 2015, Tristan Nicholson, Graduate Student (Ricke Lab), Robert E. Kates Award for excellence in clinical medicine and research, University of Rochester School of Medicine and Dentistry
  • 2015, Tristan Nicholson, Graduate Student (Ricke Lab), Glasgow-Rubin Citation for graduating 1stin Class of 2015, University of Rochester School of Medicine and Dentistry
  • 2015, Jalissa Wynder (Nguyen),Post-doc (Ricke Lab), Edward Bouchet Graduate Honor Society Inductee
  • 2015-present, William Ricke, UW Medical Foundation Professor of Urologic Research, Endowed Professorship
  • 2015-present, Teresa Liu, K12 Scholar (Ricke Lab), Investigator, NIH K Career Development Award Scholar, Department of Urology, University of Wisconsin-Madison
  • 2015-present, Chad Vezina, Associate Professor, Dept. Comparative Biosciences, University of Wisconsin-Madison
  • 2015-present, Chad Vezina, Adjunct Associate Professor, Dept. Urology, University of Wisconsin-Madison School of Medicine and Public Health
  • 2015-present, Chad Vezina, Affiliate Associate Professor, Division
  • 11/2014, Kimberly Keil, Research Assistant (Vezina Lab), Society of Basic Urology Research Travel Award
  • 04/2014, Helene Altmann, Undergraduate Researcher (Vezina Lab), Hilldale Undergraduate Research Fellowship
  • 04/2014, Bill Mulligan, Undergraduate Researcher (Vezina Lab), Hilldale Undergraduate Research Fellowship
  • 04/2014, Kimberly Keil, Research Assistant (Vezina Lab), NSF Graduate Research Fellowship
  • 04/2014, Kimberly Keil, Research Assistant (Vezina Lab), Richard F. Marsh Outstanding Graduate Student Award
  • 2014-present, William Ricke, University of Wisconsin, George M. O’Brien Center Director
  • 2014-2016, Jalissa Wynder (Nguyen),Post-doc (Ricke Lab), NIEHS (T32) Pre-doctoral Traineeship in Environmental Toxicology
  • 2014-2015, Dr. Ashleigh Theberge, K12 Scholar (Ricke Lab), Investigator, NIH K Career Development Award Scholar, Departments of Biomedical Engineering and Urology, University of Wisconsin-Madison
  • 2014, Jalissa Wynder (Nguyen),Post-doc (Ricke Lab), Travel award for Underrepresented Minority Fellows Symposium (AUMF)
  • 1988-present, Dale Bjorling, Associate Professor, University of Wisconsin, Department of Surgical Sciences
  • 1988-2011, Dale Bjorling, Department Chair, University of Wisconsin, Department of Surgical Sciences
  • 1994-present, Dale Bjorling, Professor, University of Wisconsin, Department of Surgical Sciences
  • 2008-present, Dale Bjorling, Professor, University of Wisconsin, Department of Urology
  • 2011-present, Dale Bjorling, Associate Dean for Research, University of Wisconsin, School of Veterinary Medicine